{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:17:33Z","timestamp":1791821853021,"version":"4.3.4"},"reference-count":324,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-026-00730-w","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:02:35Z","timestamp":1787209355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer pain"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-0672","authenticated-orcid":false,"given":"Eva","family":"Villalba-Riquelme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafaq","family":"Sikandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-2750","authenticated-orcid":false,"given":"Patricia","family":"Lavand\u2019homme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Logu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-8395","authenticated-orcid":false,"given":"Romina","family":"Nassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/j.pain.0000000000001363","volume":"160","author":"MI Bennett","year":"2019","unstructured":"Bennett, M. I. et al. The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. Pain 160, 38\u201344 https:\/\/doi.org\/10.1097\/j.pain.0000000000001363 (2019). This classification framework introduces the ICD-11 diagnostic entities chronic cancer-related pain and chronic treatment-related pain, shifting classification towards a standardized system that better reflects pain aetiology and supports more precise diagnosis and treatment.","journal-title":"Pain"},{"key":"730_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.pain.2011.10.028","volume":"153","author":"MI Bennett","year":"2012","unstructured":"Bennett, M. I. et al. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain 153, 359\u2013365 https:\/\/doi.org\/10.1016\/j.pain.2011.10.028 (2012).","journal-title":"Pain"},{"key":"730_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji, R.-R., Chamessian, A. & Zhang, Y.-Q. Pain regulation by non-neuronal cells and inflammation. Science 354, 572\u2013577 https:\/\/doi.org\/10.1126\/science.aaf8924 (2016). This is a relevant review establishing the neuroimmune paradigm of pain, demonstrating how immune and glial cells actively regulate nociceptive signalling rather than acting as passive bystanders.","journal-title":"Science"},{"key":"730_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.trecan.2025.01.003","volume":"11","author":"AA Martel Matos","year":"2025","unstructured":"Martel Matos, A. A. & Scheff, N. N. Sensory neurotransmission and pain in solid tumor progression. Trends Cancer 11, 309\u2013320 https:\/\/doi.org\/10.1016\/j.trecan.2025.01.003 (2025). This review summarizes current understanding of sensory neurotransmission within solid tumours and integrates emerging concepts from cancer neuroscience.","journal-title":"Trends Cancer"},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2020.03.034","volume":"181","author":"M Monje","year":"2020","unstructured":"Monje, M. et al. Roadmap for the emerging field of cancer neuroscience. Cell 181, 219\u2013222 https:\/\/doi.org\/10.1016\/j.cell.2020.03.034 (2020).","journal-title":"Cell"},{"key":"730_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00863-2","author":"P Karschnia","year":"2025","unstructured":"Karschnia, P., Nelson, T. A. & Dietrich, J. Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity. Nat. Rev. Cancer 25, 887\u2013909 https:\/\/doi.org\/10.1038\/s41568-025-00863-2 (2025). This study proposes a mechanistic framework distinguishing chemotherapy- and radiotherapy-induced neurotoxicity as separate neuropathic pain entities with persistent molecular reprogramming.","journal-title":"Nat. Rev. Cancer"},{"key":"730_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0304-3959(95)00076-3","volume":"64","author":"S Grond","year":"1996","unstructured":"Grond, S., Zech, D., Diefenbach, C., Radbruch, L. & Lehmann, K. A. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 64, 107\u2013114 https:\/\/doi.org\/10.1016\/0304-3959(95)00076-3 (1996).","journal-title":"Pain"},{"key":"730_CR8","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1002\/cncr.30839","volume":"123","author":"R Sutradhar","year":"2017","unstructured":"Sutradhar, R., Lokku, A. & Barbera, L. Cancer survivorship and opioid prescribing rates: a population-based matched cohort study among individuals with and without a history of cancer. Cancer 123, 4286\u20134293 https:\/\/doi.org\/10.1002\/cncr.30839 (2017). This large population-based cohort study was the first to show that cancer survivors have substantially higher long-term opioid prescribing rates compared with individuals without a history of cancer, highlighting survivorship as a phase of persistent analgesic need.","journal-title":"Cancer"},{"key":"730_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bjae.2024.05.002","volume":"24","author":"T Craig","year":"2024","unstructured":"Craig, T., Napolitano, A. & Brown, M. Cancer survivors and cancer pain. BJA Educ. 24, 309\u2013317 https:\/\/doi.org\/10.1016\/j.bjae.2024.05.002 (2024).","journal-title":"BJA Educ."},{"key":"730_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115692","volume":"215","author":"RJ Shi","year":"2023","unstructured":"Shi, R.-j., Ke, B.-w., Tang, Y.-l. & Liang, X.-h. Perineural invasion: a potential driver of cancer-induced pain. Biochem. Pharmacol. 215, 115692 https:\/\/doi.org\/10.1016\/j.bcp.2023.115692 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"730_CR11","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MH van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen, M. H. J., Hochstenbach, L. M. J., Joosten, E. A. J., Tjan-Heijnen, V. C. G. & Janssen, D. J. A. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J. Pain Symptom Manag. 51, 1070\u20131090 https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.340 (2016). This study presents an update on global estimate of cancer pain, demonstrating prevalence rates of 39.3% after curative treatment, 55.0% during anticancer treatment and 66.4% in advanced, metastatic or terminal disease, with ~38% of patients reporting moderate-to-severe pain despite therapeutic progress.","journal-title":"J. Pain Symptom Manag."},{"key":"730_CR12","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon, M. et al. Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann. Oncol. 29, iv166\u2013iv191 https:\/\/doi.org\/10.1093\/annonc\/mdy152 (2018). These guidelines establish multimodal, mechanism-based analgesia as the standard of care and underscore that opioids alone are insufficient for complex cancer pain.","journal-title":"Ann. Oncol."},{"key":"730_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/cancers15030591","volume":"15","author":"RAH Snijders","year":"2023","unstructured":"Snijders, R. A. H., Brom, L., Theunissen, M. & van den Beuken-van Everdingen, M. H. J. Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis. Cancers 15, 591 https:\/\/doi.org\/10.3390\/cancers15030591 (2023).","journal-title":"Cancers"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/pm\/pnaf051","volume":"26","author":"M Fern\u00e1ndez-Gualda","year":"2025","unstructured":"Fern\u00e1ndez-Gualda, M. \u00c1. et al. Prevalence and characteristics of persistent pain among head and neck cancer survivors: a systematic review and meta-analysis. Pain Med. 26, 712\u2013721 https:\/\/doi.org\/10.1093\/pm\/pnaf051 (2025).","journal-title":"Pain Med."},{"key":"730_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10620-017-4488-z","volume":"62","author":"AI Koulouris","year":"2017","unstructured":"Koulouris, A. I., Banim, P. & Hart, A. R. Pain in patients with pancreatic cancer: prevalence, mechanisms, management and future developments. Dig. Dis. Sci. 62, 861\u2013870 https:\/\/doi.org\/10.1007\/s10620-017-4488-z (2017).","journal-title":"Dig. Dis. Sci."},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00520-025-09919-3","volume":"33","author":"EG Boland","year":"2025","unstructured":"Boland, E. G. et al. Symptom prevalence in gastrointestinal cancer: a secondary analysis of IPOS data. Support. Care Cancer 33, 860 https:\/\/doi.org\/10.1007\/s00520-025-09919-3 (2025).","journal-title":"Support. Care Cancer"},{"key":"730_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.29","volume":"5","author":"P Allart-Vorelli","year":"2015","unstructured":"Allart-Vorelli, P., Porro, B., Baguet, F., Michel, A. & Cousson-G\u00e9lie, F. Haematological cancer and quality of life: a systematic literature review. Blood Cancer J. 5, e305 https:\/\/doi.org\/10.1038\/bcj.2015.29 (2015).","journal-title":"Blood Cancer J."},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.21037\/apm.2017.08.09","volume":"6","author":"Y Ahmed","year":"2017","unstructured":"Ahmed, Y. et al. Does gender affect self-perceived pain in cancer patients? \u2013 A meta-analysis. Ann. Palliat. Med. 6, S177\u2013S184 https:\/\/doi.org\/10.21037\/apm.2017.08.09 (2017). This meta-analysis examines sex-related differences in cancer pain perception and reporting.","journal-title":"Ann. Palliat. Med."},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"e2036695","DOI":"10.1001\/jamanetworkopen.2020.36695","volume":"4","author":"D Mizrahi","year":"2021","unstructured":"Mizrahi, D. et al. Hemoglobin, body mass index, and age as risk factors for paclitaxel- and oxaliplatin-induced peripheral neuropathy. JAMA Netw. Open\u00a04, e2036695 https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.36695 (2021).","journal-title":"JAMA Netw. Open"},{"key":"730_CR20","doi-asserted-by":"publisher","first-page":"oyaf036","DOI":"10.1093\/oncolo\/oyaf036","volume":"30","author":"MS von Itzstein","year":"2025","unstructured":"von Itzstein, M. S. et al. Incidence and correlates of high-grade chemotherapy-induced peripheral neuropathy in patients with lung cancer. Oncologist 30, oyaf036 https:\/\/doi.org\/10.1093\/oncolo\/oyaf036 (2025).","journal-title":"Oncologist"},{"key":"730_CR21","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1097\/ncc.0000000000000532","volume":"41","author":"PL Chou","year":"2018","unstructured":"Chou, P.-L., Fang, S.-Y., Sun, J.-L., Rau, K.-M. & Lee, B.-O. Gender difference in cancer patients\u2019 adherence to analgesics and related outcomes of pain management. Cancer Nurs. 41, E11\u2013E18 https:\/\/doi.org\/10.1097\/ncc.0000000000000532 (2018).","journal-title":"Cancer Nurs."},{"key":"730_CR22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jpainsymman.2014.02.005","volume":"48","author":"KA Martinez","year":"2014","unstructured":"Martinez, K. A., Snyder, C. F., Malin, J. L. & Dy, S. M. Is race\/ethnicity related to the presence or severity of pain in colorectal and lung cancer? J. Pain Symptom Manag. 48, 1050\u20131059 https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.02.005 (2014).","journal-title":"J. Pain Symptom Manag."},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00520-025-09779-x","volume":"33","author":"J Gabbard","year":"2025","unstructured":"Gabbard, J. et al. Patient-reported pain severity is associated with shorter survival in older adults with newly diagnosed cancer. Support. Care Cancer 33, 722 https:\/\/doi.org\/10.1007\/s00520-025-09779-x (2025).","journal-title":"Support. Care Cancer"},{"key":"730_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2011.05.065","volume":"83","author":"D Lundstedt","year":"2012","unstructured":"Lundstedt, D. et al. Risk factors of developing long-lasting breast pain after breast cancer radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 83, 71\u201378 https:\/\/doi.org\/10.1016\/j.ijrobp.2011.05.065 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.ijrobp.2010.04.007","volume":"80","author":"AC Waldenstr\u00f6m","year":"2011","unstructured":"Waldenstr\u00f6m, A.-C. et al. Pain and mean absorbed dose to the pubic bone after radiotherapy among gynecological cancer survivors. Int. J. Radiat. Oncol. Biol. Phys. 80, 1171\u20131180 https:\/\/doi.org\/10.1016\/j.ijrobp.2010.04.007 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"E352","DOI":"10.1503\/cmaj.151276","volume":"188","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. Can. Med. Assoc. J.\u00a0188, E352\u2013E361 https:\/\/doi.org\/10.1503\/cmaj.151276 (2016).","journal-title":"Can. Med. Assoc. J."},{"key":"730_CR27","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/j.1526-4637.2010.00957.x","volume":"11","author":"CR Green","year":"2010","unstructured":"Green, C. R. & Hart-Johnson, T. Cancer pain: an age-based analysis. Pain Med. 11, 1525\u20131536 https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00957.x (2010).","journal-title":"Pain Med."},{"key":"730_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1200\/jco.2017.76.0876","volume":"36","author":"LD Bubis","year":"2018","unstructured":"Bubis, L. D. et al. Symptom burden in the first year after cancer diagnosis: an analysis of patient-reported outcomes. J. Clin. Oncol. 36, 1103\u20131111 https:\/\/doi.org\/10.1200\/jco.2017.76.0876 (2018).","journal-title":"J. Clin. Oncol."},{"key":"730_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/ajp.0000000000000338","volume":"32","author":"MA Bakr","year":"2016","unstructured":"Bakr, M. A.-E.-M. et al. Comparison between the effects of intravenous morphine, tramadol, and ketorolac on stress and immune responses in patients undergoing modified radical mastectomy. Clin. J. Pain 32, 889\u2013897 https:\/\/doi.org\/10.1097\/ajp.0000000000000338 (2016).","journal-title":"Clin. J. Pain"},{"key":"730_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jss.2016.02.031","volume":"203","author":"M Hou","year":"2016","unstructured":"Hou, M. et al. Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4+CD25+Foxp3+ regulatory T cells in vitro. J. Surg. Res. 203, 306\u2013312 https:\/\/doi.org\/10.1016\/j.jss.2016.02.031 (2016).","journal-title":"J. Surg. Res."},{"key":"730_CR31","doi-asserted-by":"publisher","first-page":"e7519","DOI":"10.1097\/md.0000000000007519","volume":"96","author":"JH Cui","year":"2017","unstructured":"Cui, J.-H. et al. Effects of oxycodone on immune function in patients undergoing radical resection of rectal cancer under general anesthesia. Medicine 96, e7519 https:\/\/doi.org\/10.1097\/md.0000000000007519 (2017).","journal-title":"Medicine"},{"key":"730_CR32","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.2147\/dddt.S326891","volume":"15","author":"X Hu","year":"2021","unstructured":"Hu, X. et al. Effects of Dezocine and Sufentanil on Th1\/Th2 balance in breast cancer patients undergoing surgery. Drug Des. Dev. Ther. 15, 4925\u20134938 https:\/\/doi.org\/10.2147\/dddt.S326891 (2021).","journal-title":"Drug Des. Dev. Ther."},{"key":"730_CR33","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1097\/j.pain.0000000000001677","volume":"160","author":"T Wodehouse","year":"2019","unstructured":"Wodehouse, T. et al. A randomized pilot study to investigate the effect of opioids on immunomarkers using gene expression profiling during surgery. Pain 160, 2691\u20132698 https:\/\/doi.org\/10.1097\/j.pain.0000000000001677 (2019).","journal-title":"Pain"},{"key":"730_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejcsup.2014.03.001","volume":"12","author":"EC Moser","year":"2014","unstructured":"Moser, E. C. & Meunier, F. Cancer survivorship: a positive side-effect of more successful cancer treatment. Eur. J. Cancer Suppl. 12, 1\u20134 https:\/\/doi.org\/10.1016\/j.ejcsup.2014.03.001 (2014).","journal-title":"Eur. J. Cancer Suppl."},{"key":"730_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40265-022-01675-6","volume":"82","author":"P Glare","year":"2022","unstructured":"Glare, P. et al. Pharmacologic management of persistent pain in cancer survivors. Drugs 82, 275\u2013291 https:\/\/doi.org\/10.1007\/s40265-022-01675-6 (2022).","journal-title":"Drugs"},{"key":"730_CR36","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/s0140-6736(22)00242-2","volume":"399","author":"J Emery","year":"2022","unstructured":"Emery, J. et al. Management of common clinical problems experienced by survivors of cancer. Lancet 399, 1537\u20131550 https:\/\/doi.org\/10.1016\/s0140-6736(22)00242-2 (2022).","journal-title":"Lancet"},{"key":"730_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11764-019-00843-0","volume":"14","author":"E Cox-Martin","year":"2020","unstructured":"Cox-Martin, E., Anderson-Mellies, A., Borges, V. & Bradley, C. Chronic pain, health-related quality of life, and employment in working-age cancer survivors. J. Cancer Surviv. 14, 179\u2013187 https:\/\/doi.org\/10.1007\/s11764-019-00843-0 (2020).","journal-title":"J. Cancer Surviv."},{"key":"730_CR38","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00520-017-3613-z","volume":"25","author":"D Beckw\u00e9e","year":"2017","unstructured":"Beckw\u00e9e, D., Leysen, L., Meuwis, K. & Adriaenssens, N. Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis. Support. Care Cancer 25, 1673\u20131686 https:\/\/doi.org\/10.1007\/s00520-017-3613-z (2017).","journal-title":"Support. Care Cancer"},{"key":"730_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/eja.0000000000001974","volume":"41","author":"V Martinez","year":"2024","unstructured":"Martinez, V. et al. Chronic postsurgical pain: a European survey. Eur. J. Anaesthesiol. 41, 351\u2013362 https:\/\/doi.org\/10.1097\/eja.0000000000001974 (2024).","journal-title":"Eur. J. Anaesthesiol."},{"key":"730_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/10499091231164634","volume":"41","author":"A O\u2019Regan","year":"2024","unstructured":"O\u2019Regan, A. et al. Managing chronic pain in cancer survivorship: communication challenges and opportunities as described by cancer survivors. Am. J. Hosp. Palliat. Care 41, 78\u201386 https:\/\/doi.org\/10.1177\/10499091231164634 (2024).","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"730_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ejpain.2004.09.008","volume":"9","author":"B Zernikow","year":"2005","unstructured":"Zernikow, B. et al. Pain in pediatric oncology\u2014children\u2019s and parents\u2019 perspectives. Eur. J. Pain 9, 395\u2013406 https:\/\/doi.org\/10.1016\/j.ejpain.2004.09.008 (2005).","journal-title":"Eur. J. Pain"},{"key":"730_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/ajp.0000000000000531","volume":"34","author":"PR Tutelman","year":"2018","unstructured":"Tutelman, P. R. et al. Pain in children with cancer: prevalence, characteristics, and parent management. Clin. J. Pain 34, 198\u2013206 https:\/\/doi.org\/10.1097\/ajp.0000000000000531 (2018).","journal-title":"Clin. J. Pain"},{"key":"730_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/children9030389","volume":"9","author":"C Le-Short","year":"2022","unstructured":"Le-Short, C., Katragadda, K., Nagda, N., Farris, D. & Gelter, M. H. Interventional pain management for the pediatric cancer patient: a literature review. Children 9, 389 https:\/\/doi.org\/10.3390\/children9030389 (2022).","journal-title":"Children"},{"key":"730_CR44","unstructured":"World Health Organization. WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses (WHO, 2012)."},{"key":"730_CR45","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1200\/jco.2017.76.5552","volume":"36","author":"TM Brinkman","year":"2018","unstructured":"Brinkman, T. M., Recklitis, C. J., Michel, G., Grootenhuis, M. A. & Klosky, J. L. Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: current state of the literature. J. Clin. Oncol. 36, 2190\u20132197 https:\/\/doi.org\/10.1200\/jco.2017.76.5552 (2018).","journal-title":"J. Clin. Oncol."},{"key":"730_CR46","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.pain.2011.08.006","volume":"152","author":"Q Lu","year":"2011","unstructured":"Lu, Q. et al. Pain in long-term adult survivors of childhood cancers and their siblings: a report from the childhood cancer survivor study. Pain 152, 2616\u20132624 https:\/\/doi.org\/10.1016\/j.pain.2011.08.006 (2011).","journal-title":"Pain"},{"key":"730_CR47","doi-asserted-by":"publisher","first-page":"e250032","DOI":"10.6004\/jnccn.2025.0032","volume":"23","author":"RA Swarm","year":"2025","unstructured":"Swarm, R. A. et al. Adult cancer pain, version 2.2025, NCCN clinical practice guidelines in oncology. J. Natl Compr. Cancer Netw. 23, e250032 https:\/\/doi.org\/10.6004\/jnccn.2025.0032 (2025). These guidelines integrate interventional, neuromodulatory and non-pharmacological strategies into routine care to individualize pain management across disease stages.","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"730_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43556-025-00289-0","volume":"6","author":"WL Wang","year":"2025","unstructured":"Wang, W.-L., Hao, Y.-H., Pang, X. & Tang, Y.-L. Cancer pain: molecular mechanisms and management. Mol. Biomed. 6, 45 https:\/\/doi.org\/10.1186\/s43556-025-00289-0 (2025).","journal-title":"Mol. Biomed."},{"key":"730_CR49","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nm.1976","volume":"15","author":"M Schweizerhof","year":"2009","unstructured":"Schweizerhof, M. et al. Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat. Med. 15, 802\u2013807 https:\/\/doi.org\/10.1038\/nm.1976 (2009).","journal-title":"Nat. Med."},{"key":"730_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13402-025-01151-9","volume":"49","author":"T Hou","year":"2026","unstructured":"Hou, T., Ding, H., Huang, G., Meng, T. & Song, D. Neural-tumor crosstalk and molecular targeting: mechanisms and therapeutic implications in cancer neuroscience. Cell. Oncol. 49, 35 https:\/\/doi.org\/10.1007\/s13402-025-01151-9 (2026).","journal-title":"Cell. Oncol."},{"key":"730_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.brainres.2007.08.075","volume":"1180","author":"SG Khasabov","year":"2007","unstructured":"Khasabov, S. G., Hamamoto, D. T., Harding-Rose, C. & Simone, D. A. Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain. Brain Res. 1180, 7\u201319 https:\/\/doi.org\/10.1016\/j.brainres.2007.08.075 (2007).","journal-title":"Brain Res."},{"key":"730_CR52","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jpain.2005.08.005","volume":"6","author":"CE Urch","year":"2005","unstructured":"Urch, C. E., Donovan-Rodriguez, T., Gordon-Williams, R., Bee, L. A. & Dickenson, A. H. Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology. J. Pain 6, 837\u2013845 https:\/\/doi.org\/10.1016\/j.jpain.2005.08.005 (2005).","journal-title":"J. Pain"},{"key":"730_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pain.2003.08.002","volume":"106","author":"EC Urch","year":"2003","unstructured":"Urch, E. C., Donovan-Rodriguez, T. & Dickenson, H. A. Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain. Pain 106, 347\u2013356 https:\/\/doi.org\/10.1016\/j.pain.2003.08.002 (2003).","journal-title":"Pain"},{"key":"730_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-6-38","volume":"6","author":"Y Yanagisawa","year":"2010","unstructured":"Yanagisawa, Y. et al. Bone cancer induces a unique central sensitization through synaptic changes in a wide area of the spinal cord. Mol. Pain 6, 38 https:\/\/doi.org\/10.1186\/1744-8069-6-38 (2010).","journal-title":"Mol. Pain"},{"key":"730_CR55","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00000542-200501000-00022","volume":"102","author":"T Donovan-Rodriguez","year":"2005","unstructured":"Donovan-Rodriguez, T., Dickenson, A. H. & Urch, C. E. Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. Anesthesiology 102, 132\u2013140 https:\/\/doi.org\/10.1097\/00000542-200501000-00022 (2005).","journal-title":"Anesthesiology"},{"key":"730_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/265605","volume":"2012","author":"MP Davis","year":"2012","unstructured":"Davis, M. P. Drug management of visceral pain: concepts from basic research. Pain Res. Treat. 2012, 265605 https:\/\/doi.org\/10.1155\/2012\/265605 (2012).","journal-title":"Pain Res. Treat."},{"key":"730_CR57","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3904\/kjim.2018.162","volume":"33","author":"SY Yoon","year":"2018","unstructured":"Yoon, S. Y. & Oh, J. Neuropathic cancer pain: prevalence, pathophysiology, and management. Korean J. Intern. Med. 33, 1058\u20131069 https:\/\/doi.org\/10.3904\/kjim.2018.162 (2018).","journal-title":"Korean J. Intern. Med."},{"key":"730_CR58","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.2147\/jpr.S371337","volume":"15","author":"A Colosia","year":"2022","unstructured":"Colosia, A. et al. The burden of metastatic cancer-induced bone pain: a narrative review. J. Pain Res. 15, 3399\u20133412 https:\/\/doi.org\/10.2147\/jpr.S371337 (2022).","journal-title":"J. Pain Res."},{"key":"730_CR59","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/jco.2013.51.7219","volume":"32","author":"S Falk","year":"2014","unstructured":"Falk, S. & Dickenson, A. H. Pain and nociception: mechanisms of cancer-induced bone pain. J. Clin. Oncol. 32, 1647\u20131654 https:\/\/doi.org\/10.1200\/jco.2013.51.7219 (2014).","journal-title":"J. Clin. Oncol."},{"key":"730_CR60","doi-asserted-by":"publisher","first-page":"14649","DOI":"10.1523\/jneurosci.3300-10.2010","volume":"30","author":"JM Jimenez-Andrade","year":"2010","unstructured":"Jimenez-Andrade, J. M. et al. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J. Neurosci. 30, 14649\u201314656 https:\/\/doi.org\/10.1523\/jneurosci.3300-10.2010 (2010).","journal-title":"J. Neurosci."},{"key":"730_CR61","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.neuroscience.2010.08.056","volume":"171","author":"WG Mantyh","year":"2010","unstructured":"Mantyh, W. G. et al. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience 171, 588\u2013598 https:\/\/doi.org\/10.1016\/j.neuroscience.2010.08.056 (2010).","journal-title":"Neuroscience"},{"key":"730_CR62","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jpain.2010.12.016","volume":"12","author":"AP Bloom","year":"2011","unstructured":"Bloom, A. P. et al. Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers. J. Pain 12, 698\u2013711 https:\/\/doi.org\/10.1016\/j.jpain.2010.12.016 (2011).","journal-title":"J. Pain"},{"key":"730_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.1030899","volume":"3","author":"R Haroun","year":"2022","unstructured":"Haroun, R., Wood, J. N. & Sikandar, S. Mechanisms of cancer pain. Front. Pain Res. 3, 1030899 https:\/\/doi.org\/10.3389\/fpain.2022.1030899 (2022). This review synthesizes tumour\u2013immune\u2013neural signalling and establishes cancer pain as a neuroimmune disease driven by multi-mechanistic processes.","journal-title":"Front. Pain Res."},{"key":"730_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/SPC.0b013e32834f6ec9","volume":"6","author":"S Sikandar","year":"2012","unstructured":"Sikandar, S. & Dickenson, A. H. Visceral pain: the ins and outs, the ups and downs. Curr. Opin. Support. Palliat. Care 6, 17\u201326 https:\/\/doi.org\/10.1097\/SPC.0b013e32834f6ec9 (2012).","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"730_CR65","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/s0140-6736(99)01306-9","volume":"353","author":"F Cervero","year":"1999","unstructured":"Cervero, F. & Laird, J. M. A. Visceral pain. Lancet 353, 2145\u20132148 https:\/\/doi.org\/10.1016\/s0140-6736(99)01306-9 (1999).","journal-title":"Lancet"},{"key":"730_CR66","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc3131","volume":"11","author":"AA Bapat","year":"2011","unstructured":"Bapat, A. A., Hostetter, G., Von Hoff, D. D. & Han, H. Perineural invasion and associated pain in pancreatic cancer. Nat. Rev. Cancer 11, 695\u2013707 https:\/\/doi.org\/10.1038\/nrc3131 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"730_CR67","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1200\/jco.2009.22.4949","volume":"27","author":"C Liebig","year":"2009","unstructured":"Liebig, C. et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J. Clin. Oncol. 27, 5131\u20135137 https:\/\/doi.org\/10.1200\/jco.2009.22.4949 (2009).","journal-title":"J. Clin. Oncol."},{"key":"730_CR68","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrgastro.2015.166","volume":"12","author":"IE Demir","year":"2015","unstructured":"Demir, I. E., Friess, H. & Ceyhan, G. O. Neural plasticity in pancreatitis and pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 12, 649\u2013659 https:\/\/doi.org\/10.1038\/nrgastro.2015.166 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"730_CR69","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41568-025-00831-w","volume":"25","author":"M Amit","year":"2025","unstructured":"Amit, M. et al. Neuro-immune cross-talk in cancer. Nat. Rev. Cancer 25, 573\u2013589 https:\/\/doi.org\/10.1038\/s41568-025-00831-w (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"730_CR70","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.ccell.2025.07.019","volume":"43","author":"BM Davis","year":"2025","unstructured":"Davis, B. M., McIlvried, L. A., Saloman, J. L., Nilsen, M. L. & Scheff, N. N. Rethinking relief: targeting sensory neurons to combat cancer and pain. Cancer Cell 43, 1777\u20131782 https:\/\/doi.org\/10.1016\/j.ccell.2025.07.019 (2025).","journal-title":"Cancer Cell"},{"key":"730_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1789297","volume":"17","author":"H Liu","year":"2026","unstructured":"Liu, H., Li, X., Yu, J. & Chen, T. Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic. Front. Immunol. 17, 1789297 https:\/\/doi.org\/10.3389\/fimmu.2026.1789297 (2026).","journal-title":"Front. Immunol."},{"key":"730_CR72","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","volume":"578","author":"M Amit","year":"2020","unstructured":"Amit, M. et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 578, 449\u2013454 https:\/\/doi.org\/10.1038\/s41586-020-1996-3 (2020).","journal-title":"Nature"},{"key":"730_CR73","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41568-024-00745-z","volume":"24","author":"JA Linke","year":"2024","unstructured":"Linke, J. A., Munn, L. L. & Jain, R. K. Compressive stresses in cancer: characterization and implications for tumour progression and treatment. Nat. Rev. Cancer 24, 768\u2013791 https:\/\/doi.org\/10.1038\/s41568-024-00745-z (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"730_CR74","doi-asserted-by":"publisher","DOI":"10.1080\/19336950.2025.2517109","volume":"19","author":"C Liu","year":"2025","unstructured":"Liu, C., Li, H. & Hang, L. The research progress into cellular mechanosensitive ion channels mediating cancer pain. Channels 19, 2517109 https:\/\/doi.org\/10.1080\/19336950.2025.2517109 (2025).","journal-title":"Channels"},{"key":"730_CR75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.1193270","volume":"330","author":"B Coste","year":"2010","unstructured":"Coste, B. et al. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science 330, 55\u201360 https:\/\/doi.org\/10.1126\/science.1193270 (2010).","journal-title":"Science"},{"key":"730_CR76","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.neuron.2019.08.042","volume":"104","author":"H Kanda","year":"2019","unstructured":"Kanda, H. et al. TREK-1 and TRAAK are principal K+ channels at the nodes of Ranvier for rapid action potential conduction on mammalian myelinated afferent nerves. Neuron 104, 960\u2013971 https:\/\/doi.org\/10.1016\/j.neuron.2019.08.042 (2019).","journal-title":"Neuron"},{"key":"730_CR77","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1158\/0008-5472.Can-07-5163","volume":"68","author":"I Voloshyna","year":"2008","unstructured":"Voloshyna, I. et al. TREK-1 is a novel molecular target in prostate cancer. Cancer Res. 68, 1197\u20131203 https:\/\/doi.org\/10.1158\/0008-5472.Can-07-5163 (2008).","journal-title":"Cancer Res."},{"key":"730_CR78","doi-asserted-by":"publisher","DOI":"10.1177\/17448069211023230","volume":"17","author":"JP Liu","year":"2021","unstructured":"Liu, J.-P. et al. Contribution of TRESK two-pore domain potassium channel to bone cancer-induced spontaneous pain and evoked cutaneous pain in rats. Mol. Pain 17, 17448069211023230 https:\/\/doi.org\/10.1177\/17448069211023230 (2021).","journal-title":"Mol. Pain"},{"key":"730_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116887","volume":"176","author":"M Delanne-Cum\u00e9nal","year":"2024","unstructured":"Delanne-Cum\u00e9nal, M. et al. The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain. Biomed. Pharmacother. 176, 116887 https:\/\/doi.org\/10.1016\/j.biopha.2024.116887 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"730_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/srep08364","volume":"5","author":"C Li","year":"2015","unstructured":"Li, C. et al. Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line. Sci. Rep. 5, 8364 https:\/\/doi.org\/10.1038\/srep08364 (2015).","journal-title":"Sci. Rep."},{"key":"730_CR81","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1007\/s10620-014-3044-3","volume":"59","author":"XN Yang","year":"2014","unstructured":"Yang, X.-N. et al. Piezo1 is as a novel trefoil factor family 1 binding protein that promotes gastric cancer cell mobility in vitro. Dig. Dis. Sci. 59, 1428\u20131435 https:\/\/doi.org\/10.1007\/s10620-014-3044-3 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"730_CR82","doi-asserted-by":"publisher","first-page":"BSR20181679","DOI":"10.1042\/bsr20181679","volume":"39","author":"Z Huang","year":"2019","unstructured":"Huang, Z. et al. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration. Biosci. Rep. 39, BSR20181679 https:\/\/doi.org\/10.1042\/bsr20181679 (2019).","journal-title":"Biosci. Rep."},{"key":"730_CR83","doi-asserted-by":"publisher","first-page":"e40346","DOI":"10.1371\/journal.pone.0040346","volume":"7","author":"BJ McHugh","year":"2012","unstructured":"McHugh, B. J., Murdoch, A., Haslett, C. & Sethi, T. Loss of the integrin-activating transmembrane protein Fam38A (Piezo1) promotes a switch to a reduced integrin-dependent mode of cell migration. PLoS ONE 7, e40346 https:\/\/doi.org\/10.1371\/journal.pone.0040346 (2012).","journal-title":"PLoS ONE"},{"key":"730_CR84","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri, D. & Supuran, C. T. Interfering with pH regulation in tumours as a therapeutic strategy. Nat. Rev. Drug Discov. 10, 767\u2013777 https:\/\/doi.org\/10.1038\/nrd3554 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"730_CR85","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.bbamem.2015.02.004","volume":"1848","author":"T Yoneda","year":"2015","unstructured":"Yoneda, T., Hiasa, M., Nagata, Y., Okui, T. & White, F. Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain. Biochim. Biophys. Acta Biomembranes\u00a01848, 2677\u20132684 https:\/\/doi.org\/10.1016\/j.bbamem.2015.02.004 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"730_CR86","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/cncr.27789","volume":"119","author":"CS Cleeland","year":"2013","unstructured":"Cleeland, C. S. et al. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 119, 832\u2013838 https:\/\/doi.org\/10.1002\/cncr.27789 (2013).","journal-title":"Cancer"},{"key":"730_CR87","first-page":"287","volume":"5","author":"AF Struck","year":"2015","unstructured":"Struck, A. F., Muzahir, S. & Hall, L. T. 18F-FDG PET\/CT and pain in metastatic bone cancer. Am. J. Nucl. Med. Mol. Imaging 5, 287\u2013292 (2015).","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"730_CR88","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jpain.2006.06.003","volume":"8","author":"TJ Kim","year":"2007","unstructured":"Kim, T. J., Freml, L., Park, S. S. & Brennan, T. J. Lactate concentrations in incisions indicate ischemic-like conditions may contribute to postoperative pain. J. Pain 8, 59\u201366 https:\/\/doi.org\/10.1016\/j.jpain.2006.06.003 (2007).","journal-title":"J. Pain"},{"key":"730_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33508-6","volume":"8","author":"B Riva","year":"2018","unstructured":"Riva, B. et al. Oxaliplatin induces pH acidification in dorsal root ganglia neurons. Sci. Rep. 8, 15084 https:\/\/doi.org\/10.1038\/s41598-018-33508-6 (2018).","journal-title":"Sci. Rep."},{"key":"730_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.713944","volume":"12","author":"HY Qian","year":"2021","unstructured":"Qian, H.-Y. et al. Metformin attenuates bone cancer pain by reducing TRPV1 and ASIC3 Expression. Front. Pharmacol. 12, 713944 https:\/\/doi.org\/10.3389\/fphar.2021.713944 (2021).","journal-title":"Front. Pharmacol."},{"key":"730_CR91","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1152\/physrev.00048.2010","volume":"92","author":"G Petho","year":"2012","unstructured":"Peth\u0151, G. & Reeh, P. W. Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors. Physiol. Rev. 92, 1699\u20131775 https:\/\/doi.org\/10.1152\/physrev.00048.2010 (2012).","journal-title":"Physiol. Rev."},{"key":"730_CR92","first-page":"794","volume":"51","author":"TP Szatrowski","year":"1991","unstructured":"Szatrowski, T. P. & Nathan, C. F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51, 794\u2013798 (1991).","journal-title":"Cancer Res."},{"key":"730_CR93","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ijc.31911","volume":"144","author":"CTD Antoniazzi","year":"2019","unstructured":"Antoniazzi, C. T. D. D. et al. Transient receptor potential ankyrin 1 (TRPA1) plays a critical role in a mouse model of cancer pain. Int. J. Cancer 144, 355\u2013365 https:\/\/doi.org\/10.1002\/ijc.31911 (2019).","journal-title":"Int. J. Cancer"},{"key":"730_CR94","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1158\/0008-5472.Can-20-3326","volume":"81","author":"F De Logu","year":"2021","unstructured":"De Logu, F. et al. Peripheral nerve resident macrophages and schwann cells mediate cancer-induced pain. Cancer Res. 81, 3387\u20133401 https:\/\/doi.org\/10.1158\/0008-5472.Can-20-3326 (2021).","journal-title":"Cancer Res."},{"key":"730_CR95","doi-asserted-by":"publisher","first-page":"9426","DOI":"10.1158\/0008-5472.Can-05-0826","volume":"65","author":"KG Halvorson","year":"2005","unstructured":"Halvorson, K. G. et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res. 65, 9426\u20139435 https:\/\/doi.org\/10.1158\/0008-5472.Can-05-0826 (2005).","journal-title":"Cancer Res."},{"key":"730_CR96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbcan.2016.05.003","volume":"1866","author":"IE Demir","year":"2016","unstructured":"Demir, I. E., Tieftrunk, E., Schorn, S., Friess, H. & Ceyhan, G. O. Nerve growth factor & TrkA as novel therapeutic targets in cancer. Biochim. Biophys. Acta Rev. Cancer\u00a01866, 37\u201350 https:\/\/doi.org\/10.1016\/j.bbcan.2016.05.003 (2016).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"730_CR97","doi-asserted-by":"publisher","first-page":"8300","DOI":"10.1523\/jneurosci.2893-04.2004","volume":"24","author":"ZY Zhuang","year":"2004","unstructured":"Zhuang, Z.-Y., Xu, H., Clapham, D. E. & Ji, R.-R. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J. Neurosci. 24, 8300\u20138309 https:\/\/doi.org\/10.1523\/jneurosci.2893-04.2004 (2004).","journal-title":"J. Neurosci."},{"key":"730_CR98","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1200\/jco.1999.17.8.2419","volume":"17","author":"Z Zhu","year":"1999","unstructured":"Zhu, Z. et al. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. J. Clin. Oncol. 17, 2419\u20132428 https:\/\/doi.org\/10.1200\/jco.1999.17.8.2419 (1999).","journal-title":"J. Clin. Oncol."},{"key":"730_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-3-35","volume":"3","author":"TD Plant","year":"2007","unstructured":"Plant, T. D. et al. Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C. Mol. Pain 3, 35 https:\/\/doi.org\/10.1186\/1744-8069-3-35 (2007).","journal-title":"Mol. Pain"},{"key":"730_CR100","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1523\/jneurosci.22-15-06325.2002","volume":"22","author":"Z Zhou","year":"2002","unstructured":"Zhou, Z., Davar, G. & Strichartz, G. Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: a mechanism for the pain-inducing actions of ET-1. J. Neurosci. 22, 6325\u20136330 https:\/\/doi.org\/10.1523\/jneurosci.22-15-06325.2002 (2002).","journal-title":"J. Neurosci."},{"key":"730_CR101","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1113\/jphysiol.2006.111534","volume":"575","author":"S Amadesi","year":"2006","unstructured":"Amadesi, S. et al. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase C\u03b5- and A-dependent mechanisms in rats and mice. J. Physiol. 575, 555\u2013571 https:\/\/doi.org\/10.1113\/jphysiol.2006.111534 (2006).","journal-title":"J. Physiol."},{"key":"730_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0031-6997(25)00058-4","volume":"44","author":"KD Bhoola","year":"1992","unstructured":"Bhoola, K. D., Figueroa, C. D. & Worthy, K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1\u201380 (1992).","journal-title":"Pharmacol. Rev."},{"key":"730_CR103","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1172\/jci41084","volume":"120","author":"B Liu","year":"2010","unstructured":"Liu, B. et al. The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl\u2212 channels. J. Clin. Invest. 120, 1240\u20131252 https:\/\/doi.org\/10.1172\/jci41084 (2010).","journal-title":"J. Clin. Invest."},{"key":"730_CR104","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5152\/ejbh.2020.5730","volume":"16","author":"N Cook","year":"2020","unstructured":"Cook, N., Batt, J. & Fowler, C. Symptomatic breast cancers and why breast pain may not always need clinical review. Eur. J. Breast Health 16, 267\u2013269 https:\/\/doi.org\/10.5152\/ejbh.2020.5730 (2020).","journal-title":"Eur. J. Breast Health"},{"key":"730_CR105","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2012.10.002","volume":"63","author":"M Popiolek","year":"2013","unstructured":"Popiolek, M. et al. Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur. Urol. 63, 428\u2013435 https:\/\/doi.org\/10.1016\/j.eururo.2012.10.002 (2013).","journal-title":"Eur. Urol."},{"key":"730_CR106","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.bjc.6602714","volume":"93","author":"W Hamilton","year":"2005","unstructured":"Hamilton, W., Round, A., Sharp, D. & Peters, T. J. Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br. J. Cancer 93, 399\u2013405 https:\/\/doi.org\/10.1038\/sj.bjc.6602714 (2005).","journal-title":"Br. J. Cancer"},{"key":"730_CR107","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/cncr.11513","volume":"98","author":"BP Negin","year":"2003","unstructured":"Negin, B. P. et al. Symptoms and signs of primary melanoma: important indicators of Breslow depth. Cancer 98, 344\u2013348 https:\/\/doi.org\/10.1002\/cncr.11513 (2003).","journal-title":"Cancer"},{"key":"730_CR108","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1007\/s12035-016-0275-7","volume":"54","author":"I Brusco","year":"2017","unstructured":"Brusco, I. et al. Potentiation of paclitaxel-induced pain syndrome in mice by angiotensin I converting enzyme inhibition and involvement of kinins. Mol. Neurobiol. 54, 7824\u20137837 https:\/\/doi.org\/10.1007\/s12035-016-0275-7 (2017).","journal-title":"Mol. Neurobiol."},{"key":"730_CR109","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jamadermatol.2016.4775","volume":"153","author":"SR Frauenfelder","year":"2017","unstructured":"Frauenfelder, S. R. et al. Prostaglandin E2, tumor necrosis factor \u03b1, and pro-opiomelanocortin genes as potential mediators of cancer pain in cutaneous squamous cell carcinoma of organ transplant recipients. JAMA Dermatol. 153, 350\u2013352 https:\/\/doi.org\/10.1001\/jamadermatol.2016.4775 (2017).","journal-title":"JAMA Dermatol."},{"key":"730_CR110","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/j.pain.0000000000000130","volume":"156","author":"DK Lam","year":"2015","unstructured":"Lam, D. K., Dang, D., Flynn, A. N., Hardt, M. & Schmidt, B. L. TMPRSS2, a novel membrane-anchored mediator in cancer pain. Pain 156, 923\u2013930 https:\/\/doi.org\/10.1097\/j.pain.0000000000000130 (2015).","journal-title":"Pain"},{"key":"730_CR111","doi-asserted-by":"publisher","first-page":"e1268","DOI":"10.1093\/oncolo\/oyad188","volume":"28","author":"M Fallon","year":"2023","unstructured":"Fallon, M. et al. A randomized placebo-controlled trial of the anti-nerve growth factor antibody tanezumab in subjects with cancer pain due to bone metastasis. Oncologist 28, e1268\u2013e1278 https:\/\/doi.org\/10.1093\/oncolo\/oyad188 (2023). This clinical study shows that NGF blockade is the first mechanism-based biologic analgesic to reduce cancer-induced bone pain in randomized settings, validating the tumour\u2013nerve axis as a druggable target.","journal-title":"Oncologist"},{"key":"730_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.864910","volume":"3","author":"RL Rodwin","year":"2022","unstructured":"Rodwin, R. L., Siddiq, N. Z., Ehrlich, B. E. & Lustberg, M. B. Biomarkers of chemotherapy-induced peripheral neuropathy: current status and future directions. Front. Pain Res. 3, 864910 https:\/\/doi.org\/10.3389\/fpain.2022.864910 (2022).","journal-title":"Front. Pain Res."},{"key":"730_CR113","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/jco.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi, C. L. et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J. Clin. Oncol. 38, 3325\u20133348 https:\/\/doi.org\/10.1200\/jco.20.01399 (2020).","journal-title":"J. Clin. Oncol."},{"key":"730_CR114","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/art.39492","volume":"68","author":"MC Hochberg","year":"2016","unstructured":"Hochberg, M. C. et al. When is osteonecrosis not osteonecrosis?: Adjudication of reported serious adverse joint events in the tanezumab clinical development program. Arthritis Rheumatol. 68, 382\u2013391 https:\/\/doi.org\/10.1002\/art.39492 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"730_CR115","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.joca.2014.10.005","volume":"23","author":"MC Hochberg","year":"2015","unstructured":"Hochberg, M. C. Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies. Osteoarthritis Cartilage 23, S18\u2013S21 https:\/\/doi.org\/10.1016\/j.joca.2014.10.005 (2015).","journal-title":"Osteoarthritis Cartilage"},{"key":"730_CR116","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/1078-0432.Ccr-12-2392","volume":"19","author":"F Liebl","year":"2013","unstructured":"Liebl, F. et al. The severity of neural invasion is associated with shortened survival in colon cancer. Clin. Cancer Res. 19, 50\u201361 https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-2392 (2013).","journal-title":"Clin. Cancer Res."},{"key":"730_CR117","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.gastro.2008.09.029","volume":"136","author":"GO Ceyhan","year":"2009","unstructured":"Ceyhan, G. O. et al. Pancreatic neuropathy and neuropathic pain\u2014a comprehensive pathomorphological study of 546 cases. Gastroenterology 136, 177\u2013186 https:\/\/doi.org\/10.1053\/j.gastro.2008.09.029 (2009).","journal-title":"Gastroenterology"},{"key":"730_CR118","doi-asserted-by":"publisher","DOI":"10.1177\/17448069251323666","volume":"21","author":"S Gutierrez","year":"2025","unstructured":"Gutierrez, S. et al. Advanced cancer perineural invasion induces profound peripheral neuronal plasticity, pain, and somatosensory mechanical deactivation, unmitigated by the lack of TNFR1. Part 2. Biophysics and gene expression. Mol. Pain 21, 17448069251323666 https:\/\/doi.org\/10.1177\/17448069251323666 (2025).","journal-title":"Mol. Pain"},{"key":"730_CR119","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1053\/hupa.2001.26456","volume":"32","author":"N Maru","year":"2001","unstructured":"Maru, N., Ohori, M., Kattan, M. W., Scardino, P. T. & Wheeler, T. M. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum. Pathol. 32, 828\u2013833 https:\/\/doi.org\/10.1053\/hupa.2001.26456 (2001).","journal-title":"Hum. Pathol."},{"key":"730_CR120","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1001\/jamaoto.2017.2019","volume":"143","author":"WG Albergotti","year":"2017","unstructured":"Albergotti, W. G. et al. Defining the prevalence and prognostic value of perineural invasion and angiolymphatic invasion in human papillomavirus-positive oropharyngeal carcinoma. JAMA Otolaryngol. Head Neck Surg. 143, 1236\u20131243 https:\/\/doi.org\/10.1001\/jamaoto.2017.2019 (2017).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"730_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1572396","volume":"15","author":"M Wang","year":"2025","unstructured":"Wang, M. et al. Significance and mechanisms of perineural invasion in malignant tumors. Front. Oncol. 15, 1572396 https:\/\/doi.org\/10.3389\/fonc.2025.1572396 (2025).","journal-title":"Front. Oncol."},{"key":"730_CR122","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/1541-7786.Mcr-14-0303","volume":"13","author":"S He","year":"2015","unstructured":"He, S. et al. The chemokine (CCL2\u2013CCR2) signaling axis mediates perineural invasion. Mol. Cancer Res. 13, 380\u2013390 https:\/\/doi.org\/10.1158\/1541-7786.Mcr-14-0303 (2015).","journal-title":"Mol. Cancer Res."},{"key":"730_CR123","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1158\/0008-5472.Can-12-0764","volume":"72","author":"O Cavel","year":"2012","unstructured":"Cavel, O. et al. Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor. Cancer Res. 72, 5733\u20135743 https:\/\/doi.org\/10.1158\/0008-5472.Can-12-0764 (2012).","journal-title":"Cancer Res."},{"key":"730_CR124","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1007\/s00018-019-03149-7","volume":"76","author":"N Zarco","year":"2019","unstructured":"Zarco, N., Norton, E., Qui\u00f1ones-Hinojosa, A. & Guerrero-C\u00e1zares, H. Overlapping migratory mechanisms between neural progenitor cells and brain tumor stem cells. Cell. Mol. Life Sci. 76, 3553\u20133570 https:\/\/doi.org\/10.1007\/s00018-019-03149-7 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"730_CR125","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10286-020-00724-y","volume":"31","author":"A Kamiya","year":"2021","unstructured":"Kamiya, A., Hiyama, T., Fujimura, A. & Yoshikawa, S. Sympathetic and parasympathetic innervation in cancer: therapeutic implications. Clin. Auton. Res. 31, 165\u2013178 https:\/\/doi.org\/10.1007\/s10286-020-00724-y (2021).","journal-title":"Clin. Auton. Res."},{"key":"730_CR126","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1148\/rg.336135501","volume":"33","author":"FM Paes","year":"2013","unstructured":"Paes, F. M. et al. Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET\/CT. Radiographics 33, 1717\u20131736 https:\/\/doi.org\/10.1148\/rg.336135501 (2013).","journal-title":"Radiographics"},{"key":"730_CR127","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0166-2236(91)90024-o","volume":"14","author":"CJ Woolf","year":"1991","unstructured":"Woolf, C. J. & Walters, E. T. Common patterns of plasticity contributing to nociceptive sensitization in mammals and Aplysia. Trends Neurosci. 14, 74\u201378 https:\/\/doi.org\/10.1016\/0166-2236(91)90024-o (1991).","journal-title":"Trends Neurosci."},{"key":"730_CR128","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","volume":"7","author":"AI Basbaum","year":"1984","unstructured":"Basbaum, A. I. & Fields, H. L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7, 309\u2013338 https:\/\/doi.org\/10.1146\/annurev.ne.07.030184.001521 (1984).","journal-title":"Annu. Rev. Neurosci."},{"key":"730_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02293-2","volume":"12","author":"Y Tu","year":"2022","unstructured":"Tu, Y., Zhang, L. & Kong, J. Placebo and nocebo effects: from observation to harnessing and clinical application. Transl. Psychiatry 12, 524 https:\/\/doi.org\/10.1038\/s41398-022-02293-2 (2022).","journal-title":"Transl. Psychiatry"},{"key":"730_CR130","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.3390\/curroncol30100637","volume":"30","author":"K Shah","year":"2023","unstructured":"Shah, K. et al. Predictors and consequences of cancer and non-cancer-related pain in those diagnosed with primary and metastatic cancers. Curr. Oncol. 30, 8826\u20138840 https:\/\/doi.org\/10.3390\/curroncol30100637 (2023).","journal-title":"Curr. Oncol."},{"key":"730_CR131","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/s1470-2045(11)70002-x","volume":"12","author":"AJ Mitchell","year":"2011","unstructured":"Mitchell, A. J. et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 12, 160\u2013174 https:\/\/doi.org\/10.1016\/s1470-2045(11)70002-x (2011).","journal-title":"Lancet Oncol."},{"key":"730_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-023-01129-0","volume":"22","author":"JP Nguyen","year":"2023","unstructured":"Nguyen, J. P. et al. Bicentre, randomized, parallel-arm, sham-controlled trial of transcranial direct-current stimulation (tDCS) in the treatment of palliative care patients with refractory cancer pain. BMC Palliat. Care 22, 15 https:\/\/doi.org\/10.1186\/s12904-023-01129-0 (2023).","journal-title":"BMC Palliat. Care"},{"key":"730_CR133","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1126\/science.aax6452","volume":"365","author":"H Abdo","year":"2019","unstructured":"Abdo, H. et al. Specialized cutaneous Schwann cells initiate pain sensation. Science 365, 695\u2013699 https:\/\/doi.org\/10.1126\/science.aax6452 (2019).","journal-title":"Science"},{"key":"730_CR134","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40122-024-00679-2","volume":"14","author":"Y Du","year":"2025","unstructured":"Du, Y. et al. Repetitive transcranial magnetic stimulation: is it an effective treatment for cancer pain? Pain Ther. 14, 47\u201366 https:\/\/doi.org\/10.1007\/s40122-024-00679-2 (2025).","journal-title":"Pain Ther."},{"key":"730_CR135","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10880-022-09921-5","volume":"30","author":"F Anagnostopoulos","year":"2023","unstructured":"Anagnostopoulos, F., Paraponiari, A. & Kafetsios, K. The role of pain catastrophizing, emotional intelligence, and pain intensity in the quality of life of cancer patients with chronic pain. J. Clin. Psychol. Med. Settings 30, 501\u2013519 https:\/\/doi.org\/10.1007\/s10880-022-09921-5 (2023).","journal-title":"J. Clin. Psychol. Med. Settings"},{"key":"730_CR136","doi-asserted-by":"publisher","DOI":"10.1177\/17448069231182235","volume":"19","author":"H Ma","year":"2023","unstructured":"Ma, H., Pan, Z., Lai, B., Li, M. & Wang, J. Contribution of immune cells to cancer-related neuropathic pain: an updated review. Mol. Pain 19, 17448069231182235 https:\/\/doi.org\/10.1177\/17448069231182235 (2023).","journal-title":"Mol. Pain"},{"key":"730_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.697912","volume":"12","author":"G Bruno","year":"2021","unstructured":"Bruno, G. et al. \u03b22-and \u03b23-adrenergic receptors contribute to cancer-evoked pain in a mouse model of osteosarcoma via modulation of neural macrophages. Front. Pharmacol. 12, 697912 https:\/\/doi.org\/10.3389\/fphar.2021.697912 (2021).","journal-title":"Front. Pharmacol."},{"key":"730_CR138","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/21655979.2020.1771068","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang, Z., Song, K., Zhao, W. & Zhao, Z. Dendritic cells in tumor microenvironment promoted the neuropathic pain via paracrine inflammatory and growth factors. Bioengineered 11, 661\u2013678 https:\/\/doi.org\/10.1080\/21655979.2020.1771068 (2020).","journal-title":"Bioengineered"},{"key":"730_CR139","doi-asserted-by":"publisher","first-page":"e60529","DOI":"10.1371\/journal.pone.0060529","volume":"8","author":"IE Demir","year":"2013","unstructured":"Demir, I. E. et al. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS ONE 8, e60529 https:\/\/doi.org\/10.1371\/journal.pone.0060529 (2013).","journal-title":"PLoS ONE"},{"key":"730_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108297","volume":"240","author":"D Caba\u00f1ero","year":"2022","unstructured":"Caba\u00f1ero, D., Villalba-Riquelme, E., Fern\u00e1ndez-Ballester, G., Fern\u00e1ndez-Carvajal, A. & Ferrer-Montiel, A. ThermoTRP channels in pain sexual dimorphism: new insights for drug intervention. Pharmacol. Ther. 240, 108297 https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108297 (2022).","journal-title":"Pharmacol. Ther."},{"key":"730_CR141","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jpain.2022.08.007","volume":"24","author":"J Shin","year":"2023","unstructured":"Shin, J. et al. Perturbations in neuroinflammatory pathways are associated with a worst pain profile in oncology patients receiving chemotherapy. J. Pain 24, 84\u201397 https:\/\/doi.org\/10.1016\/j.jpain.2022.08.007 (2023).","journal-title":"J. Pain"},{"key":"730_CR142","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.Cd-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez, C. X. et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov. 10, 232\u2013253 https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-0644 (2020).","journal-title":"Cancer Discov."},{"key":"730_CR143","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang, D., Liu, J., Qian, H. & Zhuang, Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp. Mol. Med. 55, 1322\u20131332 https:\/\/doi.org\/10.1038\/s12276-023-01013-0 (2023).","journal-title":"Exp. Mol. Med."},{"key":"730_CR144","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuroscience.2012.04.065","volume":"217","author":"XW Wang","year":"2012","unstructured":"Wang, X.-W. et al. Extracellular signal-regulated kinase activation in spinal astrocytes and microglia contributes to cancer-induced bone pain in rats. Neuroscience 217, 172\u2013181 https:\/\/doi.org\/10.1016\/j.neuroscience.2012.04.065 (2012).","journal-title":"Neuroscience"},{"key":"730_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40314-w","volume":"14","author":"M Xue","year":"2023","unstructured":"Xue, M. et al. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment. Nat. Commun. 14, 4600 https:\/\/doi.org\/10.1038\/s41467-023-40314-w (2023).","journal-title":"Nat. Commun."},{"key":"730_CR146","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbi.2023.03.013","volume":"110","author":"L Landini","year":"2023","unstructured":"Landini, L. et al. Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice. Brain Behav. Immun. 110, 348\u2013364 https:\/\/doi.org\/10.1016\/j.bbi.2023.03.013 (2023).","journal-title":"Brain Behav. Immun."},{"key":"730_CR147","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1097\/j.pain.0000000000002169","volume":"162","author":"P Rinwa","year":"2021","unstructured":"Rinwa, P. et al. Demise of nociceptive Schwann cells causes nerve retraction and pain hyperalgesia. Pain 162, 1816\u20131827 https:\/\/doi.org\/10.1097\/j.pain.0000000000002169 (2021).","journal-title":"Pain"},{"key":"730_CR148","unstructured":"World Health Organization. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents (WHO, 2018)."},{"key":"730_CR149","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny, M. et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155, 2461\u20132470 https:\/\/doi.org\/10.1016\/j.pain.2014.09.020 (2014).","journal-title":"Pain"},{"key":"730_CR150","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s12672-025-03802-7","volume":"16","author":"B Zhang","year":"2025","unstructured":"Zhang, B., Lau, L. Y., Wu, Z. & Chen, Y. Chemotherapy induced neurotoxicity in cancer survivors assessed through a dual database bibliometric analysis from 2005 to 2025. Discov. Oncol. 16, 1961 https:\/\/doi.org\/10.1007\/s12672-025-03802-7 (2025).","journal-title":"Discov. Oncol."},{"key":"730_CR151","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","volume":"31","author":"B Jordan","year":"2020","unstructured":"Jordan, B. et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann. Oncol. 31, 1306\u20131319 https:\/\/doi.org\/10.1016\/j.annonc.2020.07.003 (2020). These guidelines standardize diagnostic criteria and management of chemotherapy-induced peripheral neuropathy, emphasizing early detection and mechanism-guided treatment.","journal-title":"Ann. Oncol."},{"key":"730_CR152","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","volume":"9","author":"J Burgess","year":"2021","unstructured":"Burgess, J. et al. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol. Ther. 9, 385\u2013450 https:\/\/doi.org\/10.1007\/s40487-021-00168-y (2021).","journal-title":"Oncol. Ther."},{"key":"730_CR153","first-page":"4413","volume":"31","author":"MJ Koskinen","year":"2011","unstructured":"Koskinen, M. J. et al. Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy. Anticancer Res. 31, 4413\u20134416 (2011).","journal-title":"Anticancer Res."},{"key":"730_CR154","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","volume":"10","author":"H Starobova","year":"2017","unstructured":"Starobova, H. & Vetter, I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front. Mol. Neurosci. 10, 174 https:\/\/doi.org\/10.3389\/fnmol.2017.00174 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"730_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca, L. et al. Neuropathic pain. Nat. Rev. Dis. Primers 3, 17002 https:\/\/doi.org\/10.1038\/nrdp.2017.2 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"730_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.1066069","volume":"3","author":"C Meregalli","year":"2022","unstructured":"Meregalli, C., Monza, L. & Jongen, J. L. M. A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain. Front. Pain Res. 3, 1066069 https:\/\/doi.org\/10.3389\/fpain.2022.1066069 (2022).","journal-title":"Front. Pain Res."},{"key":"730_CR157","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2147\/jpr.S213912","volume":"12","author":"P Anand","year":"2019","unstructured":"Anand, P. et al. Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification. J. Pain Res. 12, 2039\u20132052 https:\/\/doi.org\/10.2147\/jpr.S213912 (2019).","journal-title":"J. Pain Res."},{"key":"730_CR158","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1007\/s12035-018-1301-8","volume":"56","author":"VB Chine","year":"2019","unstructured":"Chine, V. B., Au, N. P. B., Kumar, G. & Ma, C. H. E. Targeting axon integrity to prevent chemotherapy-induced peripheral neuropathy. Mol. Neurobiol. 56, 3244\u20133259 https:\/\/doi.org\/10.1007\/s12035-018-1301-8 (2019).","journal-title":"Mol. Neurobiol."},{"key":"730_CR159","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.pain.2006.01.037","volume":"122","author":"SJL Flatters","year":"2006","unstructured":"Flatters, S. J. L. & Bennett, G. J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122, 245\u2013257 https:\/\/doi.org\/10.1016\/j.pain.2006.01.037 (2006).","journal-title":"Pain"},{"key":"730_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117849","volume":"183","author":"E Villalba-Riquelme","year":"2025","unstructured":"Villalba-Riquelme, E., de la Torre-Mart\u00ednez, R., Fern\u00e1ndez-Carvajal, A. & Ferrer-Montiel, A. Oxaliplatin reversibly and differentially affects electrogenic activity of small IB4(+) of male and female rat sensory neurons. Biomed. Pharmacother. 183, 117849 https:\/\/doi.org\/10.1016\/j.biopha.2025.117849 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"730_CR161","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/brain\/awab113","volume":"144","author":"EJ Akin","year":"2021","unstructured":"Akin, E. J. et al. Paclitaxel increases axonal localization and vesicular trafficking of Nav1.7. Brain 144, 1727\u20131737 https:\/\/doi.org\/10.1093\/brain\/awab113 (2021).","journal-title":"Brain"},{"key":"730_CR162","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1093\/brain\/awae071","volume":"147","author":"AP Nascimento de Lima","year":"2024","unstructured":"Nascimento de Lima, A. P. et al. Nav1.8 in small dorsal root ganglion neurons contributes to vincristine-induced mechanical allodynia. Brain 147, 3157\u20133170 https:\/\/doi.org\/10.1093\/brain\/awae071 (2024).","journal-title":"Brain"},{"key":"730_CR163","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1078155206069242","volume":"12","author":"SM Gressett","year":"2006","unstructured":"Gressett, S. M., Stanford, B. L. & Hardwicke, F. Management of hand-foot syndrome induced by capecitabine. J. Oncol. Pharm. Pract. 12, 131\u2013141 https:\/\/doi.org\/10.1177\/1078155206069242 (2006).","journal-title":"J. Oncol. Pharm. Pract."},{"key":"730_CR164","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bpa.2019.07.018","volume":"33","author":"JP Cata","year":"2019","unstructured":"Cata, J. P., Corrales, G., Speer, B. & Owusu-Agyemang, P. Postoperative acute pain challenges in patients with cancer. Best Pract. Res. Clin. Anaesthesiol. 33, 361\u2013371 https:\/\/doi.org\/10.1016\/j.bpa.2019.07.018 (2019).","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"730_CR165","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/s0140-6736(19)30352-6","volume":"393","author":"P Glare","year":"2019","unstructured":"Glare, P., Aubrey, K. R. & Myles, P. S. Transition from acute to chronic pain after surgery. Lancet 393, 1537\u20131546 https:\/\/doi.org\/10.1016\/s0140-6736(19)30352-6 (2019).","journal-title":"Lancet"},{"key":"730_CR166","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/aer.aer_24_22","volume":"16","author":"MI Ramadan","year":"2022","unstructured":"Ramadan, M. I., Khudair, H. Y. A., Obaid, A. T., Yousef, O. A. & Sammour, R. A. Prevalence of chronic postsurgical pain among cancer patients: a cross-sectional study. Anesth. Essays Res. 16, 71\u201379 https:\/\/doi.org\/10.4103\/aer.aer_24_22 (2022).","journal-title":"Anesth. Essays Res."},{"key":"730_CR167","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/jso.27441","volume":"128","author":"PR Pellegrino","year":"2023","unstructured":"Pellegrino, P. R. & Are, M. Pain management in cancer surgery: global inequities and strategies to address them. J. Surg. Oncol. 128, 1032\u20131037 https:\/\/doi.org\/10.1002\/jso.27441 (2023).","journal-title":"J. Surg. Oncol."},{"key":"730_CR168","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.radonc.2012.10.012","volume":"105","author":"S Delanian","year":"2012","unstructured":"Delanian, S., Lefaix, J.-L. & Pradat, P. F. Radiation-induced neuropathy in cancer survivors. Radiother. Oncol. 105, 273\u2013282 https:\/\/doi.org\/10.1016\/j.radonc.2012.10.012 (2012).","journal-title":"Radiother. Oncol."},{"key":"730_CR169","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41368-025-00382-8","volume":"17","author":"J Xia","year":"2025","unstructured":"Xia, J. et al. Expert consensus on the prevention and treatment of radiochemotherapy-induced oral mucositis. Int. J. Oral Sci. 17, 54 https:\/\/doi.org\/10.1038\/s41368-025-00382-8 (2025).","journal-title":"Int. J. Oral Sci."},{"key":"730_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101886","volume":"58","author":"T Behroozian","year":"2023","unstructured":"Behroozian, T. et al. MASCC clinical practice guidelines for the prevention and management of acute radiation dermatitis: part 1) systematic review. eClinicalMedicine 58, 101886 https:\/\/doi.org\/10.1016\/j.eclinm.2023.101886 (2023).","journal-title":"eClinicalMedicine"},{"key":"730_CR171","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/annonc\/mdu011","volume":"25","author":"CI Ripamonti","year":"2014","unstructured":"Ripamonti, C. I., Bossi, P., Santini, D. & Fallon, M. Pain related to cancer treatments and diagnostic procedures: a no man\u2019s land? Ann. Oncol. 25, 1097\u20131106 https:\/\/doi.org\/10.1093\/annonc\/mdu011 (2014).","journal-title":"Ann. Oncol."},{"key":"730_CR172","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.oraloncology.2019.05.014","volume":"95","author":"Y Dong","year":"2019","unstructured":"Dong, Y. et al. Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer. Oral Oncol. 95, 59\u201364 https:\/\/doi.org\/10.1016\/j.oraloncology.2019.05.014 (2019).","journal-title":"Oral Oncol."},{"key":"730_CR173","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/annonc\/mdn646","volume":"20","author":"V Ziller","year":"2009","unstructured":"Ziller, V. et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann. Oncol. 20, 431\u2013436 https:\/\/doi.org\/10.1093\/annonc\/mdn646 (2009).","journal-title":"Ann. Oncol."},{"key":"730_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.713700","volume":"12","author":"T Hyder","year":"2021","unstructured":"Hyder, T., Marino, C. C., Ahmad, S., Nasrazadani, A. & Brufsky, A. M. Aromatase inhibitor-associated musculoskeletal syndrome: understanding mechanisms and management. Front. Endocrinol. 12, 713700 https:\/\/doi.org\/10.3389\/fendo.2021.713700 (2021).","journal-title":"Front. Endocrinol."},{"key":"730_CR175","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","volume":"33","author":"J Haanen","year":"2022","unstructured":"Haanen, J. et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 1217\u20131238 https:\/\/doi.org\/10.1016\/j.annonc.2022.10.001 (2022).","journal-title":"Ann. Oncol."},{"key":"730_CR176","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","volume":"83","author":"AN Geisler","year":"2020","unstructured":"Geisler, A. N. et al. Immune checkpoint inhibitor-related dermatologic adverse events. J. Am. Acad. Dermatol. 83, 1255\u20131268 https:\/\/doi.org\/10.1016\/j.jaad.2020.03.132 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"730_CR177","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11886-021-01530-2","volume":"23","author":"DJ Lee","year":"2021","unstructured":"Lee, D. J., Lee, H. J. Jr, Farmer, J. R. & Reynolds, K. L. Mechanisms driving immune-related adverse events in cancer patients treated with immune checkpoint inhibitors. Curr. Cardiol. Rep. 23, 98 https:\/\/doi.org\/10.1007\/s11886-021-01530-2 (2021).","journal-title":"Curr. Cardiol. Rep."},{"key":"730_CR178","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/jco.21.01440","volume":"39","author":"BJ Schneider","year":"2021","unstructured":"Schneider, B. J. et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J. Clin. Oncol. 39, 4073\u20134126 https:\/\/doi.org\/10.1200\/jco.21.01440 (2021).","journal-title":"J. Clin. Oncol."},{"key":"730_CR179","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1007\/s00520-019-04831-z","volume":"27","author":"A Lemaire","year":"2019","unstructured":"Lemaire, A. et al. Opening up disruptive ways of management in cancer pain: the concept of multimorphic pain. Support. Care Cancer 27, 3159\u20133170 https:\/\/doi.org\/10.1007\/s00520-019-04831-z (2019). This review introduces the concept of multimorphic cancer pain, emphasizing the coexistence of multiple pain mechanisms within individual patients.","journal-title":"Support. Care Cancer"},{"key":"730_CR180","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb, S. et al. Systematic review of complications of prostate biopsy. Eur. Urol. 64, 876\u2013892 https:\/\/doi.org\/10.1016\/j.eururo.2013.05.049 (2013).","journal-title":"Eur. Urol."},{"key":"730_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35426-8","volume":"13","author":"D J Ghadimi","year":"2023","unstructured":"Ghadimi, J. D., Looha, M. A., Akbari, M. E. & Akbari, A. Predictors of postoperative pain six months after breast surgery. Sci. Rep. 13, 8302 https:\/\/doi.org\/10.1038\/s41598-023-35426-8 (2023).","journal-title":"Sci. Rep."},{"key":"730_CR182","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/j.pmn.2023.12.001","volume":"25","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Pain sensitivity and acute postoperative pain in patients undergoing abdominal surgery: the mediating roles of pain self-efficacy and pain catastrophizing. Pain Manag. Nurs. 25, e108\u2013e114 https:\/\/doi.org\/10.1016\/j.pmn.2023.12.001 (2024).","journal-title":"Pain Manag. Nurs."},{"key":"730_CR183","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00520-020-05462-5","volume":"29","author":"E Lam","year":"2021","unstructured":"Lam, E. et al. Self-reported pain in breast cancer patients receiving adjuvant radiotherapy. Support. Care Cancer 29, 155\u2013167 https:\/\/doi.org\/10.1007\/s00520-020-05462-5 (2021).","journal-title":"Support. Care Cancer"},{"key":"730_CR184","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.1200\/jop.2014.001776","volume":"10","author":"DL Hershman","year":"2014","unstructured":"Hershman, D. L., Lacchetti, C. & Loprinzi, C. L. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline summary. J. Oncol. Pract. 10, e421\u2013e424 https:\/\/doi.org\/10.1200\/jop.2014.001776 (2014).","journal-title":"J. Oncol. Pract."},{"key":"730_CR185","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/j.pain.0000000000000895","volume":"158","author":"D Bouhassira","year":"2017","unstructured":"Bouhassira, D., Luporsi, E. & Krakowski, I. Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer. Pain 158, 1118\u20131125 https:\/\/doi.org\/10.1097\/j.pain.0000000000000895 (2017).","journal-title":"Pain"},{"key":"730_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1659490","volume":"12","author":"G Varrassi","year":"2025","unstructured":"Varrassi, G. et al. Mixed pain: clinical practice recommendations. Front. Med. 12, 1659490 https:\/\/doi.org\/10.3389\/fmed.2025.1659490 (2025).","journal-title":"Front. Med."},{"key":"730_CR187","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00482-015-0093-2","volume":"35","author":"M M\u00fccke","year":"2021","unstructured":"M\u00fccke, M. et al. Quantitative sensory testing (QST). English version. Schmerz 35, 153\u2013160 https:\/\/doi.org\/10.1007\/s00482-015-0093-2 (2021).","journal-title":"Schmerz"},{"key":"730_CR188","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1577","volume":"5","author":"F van Haren","year":"2022","unstructured":"van Haren, F., van den Heuvel, S., Ligtenberg, M., Vissers, K. & Steegers, M. Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes. Cancer Rep. 5, e1577 https:\/\/doi.org\/10.1002\/cnr2.1577 (2022).","journal-title":"Cancer Rep."},{"key":"730_CR189","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-026-15750-8","volume":"26","author":"R Brownson-Smith","year":"2026","unstructured":"Brownson-Smith, R. et al. Longitudinal assessment of chemotherapy-induced peripheral neuropathy in women undergoing taxane-based treatment for breast cancer: a prospective observational study. BMC Cancer 26, 404 https:\/\/doi.org\/10.1186\/s12885-026-15750-8 (2026).","journal-title":"BMC Cancer"},{"key":"730_CR190","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/jns.12413","volume":"25","author":"K Bennedsgaard","year":"2020","unstructured":"Bennedsgaard, K. et al. Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics. J. Peripher. Nerv. Syst. 25, 377\u2013387 https:\/\/doi.org\/10.1111\/jns.12413 (2020).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"730_CR191","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/ejp.1988","volume":"26","author":"KK Petersen","year":"2022","unstructured":"Petersen, K. K.-S. et al. The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis\u2014a randomized, double-blind, placebo-controlled, crossover study. Eur. J. Pain 26, 1650\u20131664 https:\/\/doi.org\/10.1002\/ejp.1988 (2022).","journal-title":"Eur. J. Pain"},{"key":"730_CR192","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/jnnp.54.8.706","volume":"54","author":"RB Lipton","year":"1991","unstructured":"Lipton, R. B. et al. Large and small fibre type sensory dysfunction in patients with cancer. J. Neurol. Neurosurg. Psychiatry 54, 706\u2013709 https:\/\/doi.org\/10.1136\/jnnp.54.8.706 (1991).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"730_CR193","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejpain.2011.05.002","volume":"16","author":"AC Scott","year":"2012","unstructured":"Scott, A. C., McConnell, S., Laird, B., Colvin, L. & Fallon, M. Quantitative sensory testing to assess the sensory characteristics of cancer-induced bone pain after radiotherapy and potential clinical biomarkers of response. Eur. J. Pain 16, 123\u2013133 https:\/\/doi.org\/10.1016\/j.ejpain.2011.05.002 (2012).","journal-title":"Eur. J. Pain"},{"key":"730_CR194","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.pan.2025.04.010","volume":"25","author":"M Faghih","year":"2025","unstructured":"Faghih, M. et al. Pancreatic adenocarcinoma patients with pain have abnormal central pain processing. Pancreatology 25, 426\u2013432 https:\/\/doi.org\/10.1016\/j.pan.2025.04.010 (2025).","journal-title":"Pancreatology"},{"key":"730_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.936012","volume":"13","author":"D Liu","year":"2022","unstructured":"Liu, D. et al. Altered brain functional activity and connectivity in bone metastasis pain of lung cancer patients: a preliminary resting-state fMRI study. Front. Neurol. 13, 936012 https:\/\/doi.org\/10.3389\/fneur.2022.936012 (2022).","journal-title":"Front. Neurol."},{"key":"730_CR196","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3389\/fpsyg.2016.01466","volume":"7","author":"AM Boonstra","year":"2016","unstructured":"Boonstra, A. M. et al. Cut-off points for mild, moderate, and severe pain on the numeric rating scale for pain in patients with chronic musculoskeletal pain: variability and influence of sex and catastrophizing. Front. Psychol. 7, 1466 https:\/\/doi.org\/10.3389\/fpsyg.2016.01466 (2016).","journal-title":"Front. Psychol."},{"key":"730_CR197","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpain.2015.10.001","volume":"17","author":"S Baudic","year":"2016","unstructured":"Baudic, S. et al. Effect of alexithymia and emotional repression on postsurgical pain in women with breast cancer: a prospective longitudinal 12-month study. J. Pain 17, 90\u2013100 https:\/\/doi.org\/10.1016\/j.jpain.2015.10.001 (2016).","journal-title":"J. Pain"},{"key":"730_CR198","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-177","volume":"8","author":"A Tavoli","year":"2008","unstructured":"Tavoli, A., Montazeri, A., Roshan, R., Tavoli, Z. & Melyani, M. Depression and quality of life in cancer patients with and without pain: the role of pain beliefs. BMC Cancer 8, 177 https:\/\/doi.org\/10.1186\/1471-2407-8-177 (2008).","journal-title":"BMC Cancer"},{"key":"730_CR199","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1007\/s00520-022-06805-0","volume":"30","author":"L Dams","year":"2022","unstructured":"Dams, L. et al. Biopsychosocial risk factors for pain and pain-related disability 1 year after surgery for breast cancer. Support. Care Cancer 30, 4465\u20134475 https:\/\/doi.org\/10.1007\/s00520-022-06805-0 (2022).","journal-title":"Support. Care Cancer"},{"key":"730_CR200","first-page":"37","volume":"90","author":"RR Gulati","year":"2021","unstructured":"Gulati, R. R. The challenge of cancer pain assessment. Ulster Med. J. 90, 37\u201340 (2021).","journal-title":"Ulster Med. J."},{"key":"730_CR201","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1634\/theoncologist.2015-0026","volume":"20","author":"M Delgado-Guay","year":"2015","unstructured":"Delgado-Guay, M. et al. Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. Oncologist 20, 1092\u20131098 https:\/\/doi.org\/10.1634\/theoncologist.2015-0026 (2015).","journal-title":"Oncologist"},{"key":"730_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113691","volume":"155","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Perineural invasion-associated biomarkers for tumor development. Biomed. Pharmacother. 155, 113691 https:\/\/doi.org\/10.1016\/j.biopha.2022.113691 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"730_CR203","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/147323000803600406","volume":"36","author":"Q Zeng","year":"2008","unstructured":"Zeng, Q. et al. The relationship between overexpression of glial cell-derived neurotrophic factor and its RET receptor with progression and prognosis of human pancreatic cancer. J. Int. Med. Res. 36, 656\u2013664 https:\/\/doi.org\/10.1177\/147323000803600406 (2008).","journal-title":"J. Int. Med. Res."},{"key":"730_CR204","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/jco.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch, E. et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J. Clin. Oncol. 34, 557\u2013565 https:\/\/doi.org\/10.1200\/jco.2015.63.0830 (2016).","journal-title":"J. Clin. Oncol."},{"key":"730_CR205","doi-asserted-by":"publisher","unstructured":"Kasasbeh, M. A. M., McCabe, C. & Payne, S. Cancer-related pain management: a review of knowledge and attitudes of healthcare professionals. Eur. J. Cancer Care https:\/\/doi.org\/10.1111\/ecc.12625 (2017).","DOI":"10.1111\/ecc.12625"},{"key":"730_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.nepr.2022.103390","volume":"63","author":"MI Ortiz","year":"2022","unstructured":"Ortiz, M. I., Cuevas-Su\u00e1rez, C. E., Cari\u00f1o-Cort\u00e9s, R., Navarrete-Hern\u00e1ndez, J. d. J. & Gonz\u00e1lez-Montiel, C. A. Nurses knowledge and attitude regarding pain: a systematic review and meta-analysis. Nurse Educ. Pract. 63, 103390 https:\/\/doi.org\/10.1016\/j.nepr.2022.103390 (2022).","journal-title":"Nurse Educ. Pract."},{"key":"730_CR207","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/s0889-8588(02)00065-5","volume":"16","author":"BR Furrow","year":"2002","unstructured":"Furrow, B. R. Pain management and liability issues. Hematol. Oncol. Clin. N. Am. 16, 1483\u20131494 https:\/\/doi.org\/10.1016\/s0889-8588(02)00065-5 (2002).","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"730_CR208","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0885-3924(02)00542-0","volume":"25","author":"CC Lin","year":"2003","unstructured":"Lin, C.-C., Lai, Y.-L. & Ward, S. E. Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients. J. Pain Symptom Manag. 25, 29\u201337 https:\/\/doi.org\/10.1016\/s0885-3924(02)00542-0 (2003).","journal-title":"J. Pain Symptom Manag."},{"key":"730_CR209","doi-asserted-by":"publisher","first-page":"e816","DOI":"10.1097\/pr9.0000000000000816","volume":"5","author":"DE Schoth","year":"2020","unstructured":"Schoth, D. E., Radhakrishnan, K. & Liossi, C. A systematic review with subset meta-analysis of studies exploring memory recall biases for pain-related information in adults with chronic pain. Pain Rep. 5, e816 https:\/\/doi.org\/10.1097\/pr9.0000000000000816 (2020).","journal-title":"Pain Rep."},{"key":"730_CR210","doi-asserted-by":"publisher","first-page":"e1030","DOI":"10.1200\/op.20.01041","volume":"17","author":"Y Schenker","year":"2021","unstructured":"Schenker, Y. et al. This is a different patient population: opioid prescribing challenges for patients with cancer-related pain. JCO Oncol. Pract. 17, e1030\u2013e1037 https:\/\/doi.org\/10.1200\/op.20.01041 (2021).","journal-title":"JCO Oncol. Pract."},{"key":"730_CR211","first-page":"195","volume":"7","author":"J Stjernsw\u00e4rd","year":"1988","unstructured":"Stjernsw\u00e4rd, J. WHO cancer pain relief programme. Cancer Surv. 7, 195\u2013208 (1988).","journal-title":"Cancer Surv."},{"key":"730_CR212","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/s1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni, A. et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 13, e58\u201368 https:\/\/doi.org\/10.1016\/s1470-2045(12)70040-2 (2012).","journal-title":"Lancet Oncol."},{"key":"730_CR213","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/jco.2016.68.5206","volume":"34","author":"JA Paice","year":"2016","unstructured":"Paice, J. A. et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J. Clin. Oncol. 34, 3325\u20133345 https:\/\/doi.org\/10.1200\/jco.2016.68.5206 (2016).","journal-title":"J. Clin. Oncol."},{"key":"730_CR214","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.7573\/dic.2022-11-7","volume":"12","author":"G Porzio","year":"2023","unstructured":"Porzio, G. et al. Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature. Drugs Context\u00a012, 2022-11-7 https:\/\/doi.org\/10.7573\/dic.2022-11-7 (2023).","journal-title":"Drugs Context"},{"key":"730_CR215","doi-asserted-by":"publisher","DOI":"10.1177\/26323524221125244","volume":"16","author":"CA Gomes-Ferraz","year":"2022","unstructured":"Gomes-Ferraz, C. A., Rezende, G., Fagundes, A. A. & De Carlo, M. M. R. d. P. Assessment of total pain in people in oncologic palliative care: integrative literature review. Palliat. Care Soc. Pract. 16, 26323524221125244 https:\/\/doi.org\/10.1177\/26323524221125244 (2022).","journal-title":"Palliat. Care Soc. Pract."},{"key":"730_CR216","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/s2468-2667(22)00013-5","volume":"7","author":"C Ju","year":"2022","unstructured":"Ju, C. et al. Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study. Lancet Public. Health 7, e335\u2013e346 https:\/\/doi.org\/10.1016\/s2468-2667(22)00013-5 (2022).","journal-title":"Lancet Public. Health"},{"key":"730_CR217","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/s0140-6736(17)32513-8","volume":"391","author":"FM Knaul","year":"2018","unstructured":"Knaul, F. M. et al. Alleviating the access abyss in palliative care and pain relief\u2014an imperative of universal health coverage: the Lancet Commission report. Lancet 391, 1391\u20131454 https:\/\/doi.org\/10.1016\/s0140-6736(17)32513-8 (2018). A landmark Lancet Commission report highlighting global disparities in access to pain relief, particularly opioids.","journal-title":"Lancet"},{"key":"730_CR218","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/papr.13098","volume":"22","author":"A Roberto","year":"2022","unstructured":"Roberto, A. et al. Living systematic review to assess the analgesic undertreatment in cancer patients. Pain Pract. 22, 487\u2013496 https:\/\/doi.org\/10.1111\/papr.13098 (2022).","journal-title":"Pain Pract."},{"key":"730_CR219","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.3390\/curroncol30070500","volume":"30","author":"F Mestdagh","year":"2023","unstructured":"Mestdagh, F., Steyaert, A. & Lavand\u2019homme, P. Cancer pain management: a narrative review of current concepts, strategies, and techniques. Curr. Oncol. 30, 6838\u20136858 https:\/\/doi.org\/10.3390\/curroncol30070500 (2023).","journal-title":"Curr. Oncol."},{"key":"730_CR220","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/384644a0","volume":"384","author":"RG Kurumbail","year":"1996","unstructured":"Kurumbail, R. G. et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384, 644\u2013648 https:\/\/doi.org\/10.1038\/384644a0 (1996).","journal-title":"Nature"},{"key":"730_CR221","doi-asserted-by":"publisher","DOI":"10.1186\/ar4134","volume":"15","author":"A Moore","year":"2013","unstructured":"Moore, A., Makinson, G. & Li, C. Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials. Arthritis Res. Ther. 15, R6 https:\/\/doi.org\/10.1186\/ar4134 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"730_CR222","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Bhala, N. et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382, 769\u2013779 https:\/\/doi.org\/10.1016\/s0140-6736(13)60900-9 (2013).","journal-title":"Lancet"},{"key":"730_CR223","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/gutjnl-2019-319300","volume":"69","author":"CC Szeto","year":"2020","unstructured":"Szeto, C.-C. et al. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE\/APLAR\/APSDE\/APSH\/APSN\/PoA recommendations. Gut 69, 617\u2013629 https:\/\/doi.org\/10.1136\/gutjnl-2019-319300 (2020).","journal-title":"Gut"},{"key":"730_CR224","doi-asserted-by":"publisher","first-page":"CD012637","DOI":"10.1002\/14651858.CD012637.pub2","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen, P. J. et al. Oral paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst. Rev. 7, CD012637 https:\/\/doi.org\/10.1002\/14651858.CD012637.pub2 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"730_CR225","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14218\/jcth.2015.00052","volume":"4","author":"E Yoon","year":"2016","unstructured":"Yoon, E., Babar, A., Choudhary, M., Kutner, M. & Pyrsopoulos, N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J. Clin. Transl. Hepatol. 4, 131\u2013142 https:\/\/doi.org\/10.14218\/jcth.2015.00052 (2016).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"730_CR226","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T. & Chou, R. CDC Clinical Practice Guideline for prescribing opioids for pain\u00a0\u2014 United States, 2022. Morbid. Mortal. Wkly Rep. Recomm. Rep.\u00a071, 1\u201395 https:\/\/doi.org\/10.15585\/mmwr.rr7103a1 (2022).","journal-title":"Morbid. Mortal. Wkly Rep. Recomm. Rep."},{"key":"730_CR227","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/383819a0","volume":"383","author":"HW Matthes","year":"1996","unstructured":"Matthes, H. W. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the \u03bc-opioid-receptor gene. Nature 383, 819\u2013823 https:\/\/doi.org\/10.1038\/383819a0 (1996).","journal-title":"Nature"},{"key":"730_CR228","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","volume":"67","author":"C Stein","year":"2016","unstructured":"Stein, C. Opioid receptors. Annu. Rev. Med. 67, 433\u2013451 https:\/\/doi.org\/10.1146\/annurev-med-062613-093100 (2016).","journal-title":"Annu. Rev. Med."},{"key":"730_CR229","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1200\/jco.2013.53.1079","volume":"32","author":"GW Pasternak","year":"2014","unstructured":"Pasternak, G. W. Opiate pharmacology and relief of pain. J. Clin. Oncol. 32, 1655\u20131661 https:\/\/doi.org\/10.1200\/jco.2013.53.1079 (2014).","journal-title":"J. Clin. Oncol."},{"key":"730_CR230","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0014-2999(00)00819-0","volume":"410","author":"KS LaForge","year":"2000","unstructured":"LaForge, K. S., Yuferov, V. & Kreek, M. J. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur. J. Pharmacol. 410, 249\u2013268 https:\/\/doi.org\/10.1016\/s0014-2999(00)00819-0 (2000).","journal-title":"Eur. J. Pharmacol."},{"key":"730_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.57.1.1","volume":"57","author":"MJ Kreek","year":"2005","unstructured":"Kreek, M. J., Bart, G., Lilly, C., LaForge, K. S. & Nielsen, D. A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol. Rev. 57, 1\u201326 https:\/\/doi.org\/10.1124\/pr.57.1.1 (2005).","journal-title":"Pharmacol. Rev."},{"key":"730_CR232","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2125.2012.04317.x","volume":"75","author":"AM Drewes","year":"2013","unstructured":"Drewes, A. M. et al. Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br. J. Clin. Pharmacol. 75, 60\u201378 https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04317.x (2013).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"730_CR233","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.annonc.2022.08.083","volume":"33","author":"M Fallon","year":"2022","unstructured":"Fallon, M. et al. An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancer. Ann. Oncol. 33, 1296\u20131303 https:\/\/doi.org\/10.1016\/j.annonc.2022.08.083 (2022).","journal-title":"Ann. Oncol."},{"key":"730_CR234","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12094-017-1791-2","volume":"20","author":"C Jara","year":"2018","unstructured":"Jara, C. et al. SEOM clinical guideline for treatment of cancer pain (2017). Clin. Transl. Oncol. 20, 97\u2013107 https:\/\/doi.org\/10.1007\/s12094-017-1791-2 (2018).","journal-title":"Clin. Transl. Oncol."},{"key":"730_CR235","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40360-022-00632-z","volume":"23","author":"Q Wang","year":"2022","unstructured":"Wang, Q., Liu, Z., Tang, S. & Wu, Z. Morphine suppresses the immune function of lung cancer by up-regulating MAEL expression. BMC Pharmacol. Toxicol. 23, 92 https:\/\/doi.org\/10.1186\/s40360-022-00632-z (2022).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"730_CR236","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/j.bja.2018.09.019","volume":"122","author":"C Higgins","year":"2019","unstructured":"Higgins, C., Smith, B. H. & Matthews, K. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br. J. Anaesth. 122, e114\u2013e126 https:\/\/doi.org\/10.1016\/j.bja.2018.09.019 (2019).","journal-title":"Br. J. Anaesth."},{"key":"730_CR237","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bpa.2017.05.003","volume":"31","author":"P Lavand\u2019homme","year":"2017","unstructured":"Lavand\u2019homme, P. & Steyaert, A. Opioid-free anesthesia opioid side effects: tolerance and hyperalgesia. Best Pract. Res. Clin. Anaesthesiol. 31, 487\u2013498 https:\/\/doi.org\/10.1016\/j.bpa.2017.05.003 (2017).","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"730_CR238","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/s1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup, N. B. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 14, 162\u2013173 https:\/\/doi.org\/10.1016\/s1474-4422(14)70251-0 (2015).","journal-title":"Lancet Neurol."},{"key":"730_CR239","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jpainsymman.2019.06.020","volume":"58","author":"H Matsuoka","year":"2019","unstructured":"Matsuoka, H. et al. Additive duloxetine for cancer-related neuropathic pain nonresponsive or intolerant to opioid-pregabalin therapy: a randomized controlled trial (JORTC-PAL08). J. Pain Symptom Manag.\u00a058, 645\u2013653 https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.06.020 (2019).","journal-title":"J. Pain Symptom Manag."},{"key":"730_CR240","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.21037\/apm-20-1455","volume":"10","author":"ZA Curry","year":"2021","unstructured":"Curry, Z. A., Dang, M. C., Sima, A. P., Abdullaziz, S. & Del Fabbro, E. G. Combination therapy with methadone and duloxetine for cancer-related pain: a retrospective study. Ann. Palliat. Med. 10, 2505\u20132511 https:\/\/doi.org\/10.21037\/apm-20-1455 (2021).","journal-title":"Ann. Palliat. Med."},{"key":"730_CR241","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0304-3959(95)00138-7","volume":"64","author":"K Eija","year":"1996","unstructured":"Kalso, E., Tasmuth, T. & Neuvonen, P. J. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 64, 293\u2013302 https:\/\/doi.org\/10.1016\/0304-3959(95)00138-7 (1996).","journal-title":"Pain"},{"key":"730_CR242","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41594-023-01013-8","volume":"30","author":"L Ferron","year":"2023","unstructured":"Ferron, L., Gandini, M. A. & Zamponi, G. W. Fighting pain: the structure of gabapentin and its binding site in the Cav\u03b12\u03b4 subunit. Nat. Struct. Mol. Biol. 30, 717\u2013719 https:\/\/doi.org\/10.1038\/s41594-023-01013-8 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"730_CR243","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1200\/jco.2004.08.141","volume":"22","author":"A Caraceni","year":"2004","unstructured":"Caraceni, A. et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J. Clin. Oncol. 22, 2909\u20132917 https:\/\/doi.org\/10.1200\/jco.2004.08.141 (2004).","journal-title":"J. Clin. Oncol."},{"key":"730_CR244","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","volume":"31","author":"R Coleman","year":"2020","unstructured":"Coleman, R. et al. Bone health in cancer: ESMO clinical practice guidelines. Ann. Oncol. 31, 1650\u20131663 https:\/\/doi.org\/10.1016\/j.annonc.2020.07.019 (2020).","journal-title":"Ann. Oncol."},{"key":"730_CR245","doi-asserted-by":"publisher","DOI":"10.1177\/10732748261427063","volume":"33","author":"N Wang","year":"2026","unstructured":"Wang, N., Song, F., Li, X. & Chen, H. Denosumab plus immune checkpoint inhibitors in bone metastases from solid tumors. Cancer Control 33, 10732748261427063 https:\/\/doi.org\/10.1177\/10732748261427063 (2026).","journal-title":"Cancer Control"},{"key":"730_CR246","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.21037\/apm.2019.09.09","volume":"9","author":"KWA Cheung","year":"2020","unstructured":"Cheung, K. W. A., Chan, P. C. & Lo, S. H. The use of ketamine in the management of refractory cancer pain in a palliative care unit. Ann. Palliat. Med. 9, 4478\u20134489 https:\/\/doi.org\/10.21037\/apm.2019.09.09 (2020).","journal-title":"Ann. Palliat. Med."},{"key":"730_CR247","doi-asserted-by":"publisher","first-page":"e656","DOI":"10.1136\/bmjspcare-2018-001739","volume":"12","author":"M Courade","year":"2022","unstructured":"Courade, M. et al. Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study. BMJ Support. Palliat. Care 12, e656\u2013e663 https:\/\/doi.org\/10.1136\/bmjspcare-2018-001739 (2022).","journal-title":"BMJ Support. Palliat. Care"},{"key":"730_CR248","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.4764","volume":"29","author":"F Minnai","year":"2025","unstructured":"Minnai, F. et al. A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity. Eur. J. Pain 29, e4764 https:\/\/doi.org\/10.1002\/ejp.4764 (2025).","journal-title":"Eur. J. Pain"},{"key":"730_CR249","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s2468-1253(18)30008-6","volume":"3","author":"AD Farmer","year":"2018","unstructured":"Farmer, A. D. et al. Pathophysiology, diagnosis, and management of opioid-induced constipation. Lancet Gastroenterol. Hepatol. 3, 203\u2013212 https:\/\/doi.org\/10.1016\/s2468-1253(18)30008-6 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"730_CR250","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s10620-018-5394-8","volume":"64","author":"T Sommers","year":"2019","unstructured":"Sommers, T. et al. Significant morbidity and mortality associated with fecal impaction in patients who present to the emergency department. Dig. Dis. Sci. 64, 1320\u20131327 https:\/\/doi.org\/10.1007\/s10620-018-5394-8 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"730_CR251","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/2049463712438299","volume":"6","author":"O Seyfried","year":"2012","unstructured":"Seyfried, O. & Hester, J. Opioids and endocrine dysfunction. Br. J. Pain 6, 17\u201324 https:\/\/doi.org\/10.1177\/2049463712438299 (2012).","journal-title":"Br. J. Pain"},{"key":"730_CR252","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/dddt.S342409","volume":"16","author":"A Kotli\u0144ska-Lemieszek","year":"2022","unstructured":"Kotli\u0144ska-Lemieszek, A. & \u017bylicz, Z. Less well-known consequences of the long-term use of opioid analgesics: a comprehensive literature review. Drug Des. Dev. Ther. 16, 251\u2013264 https:\/\/doi.org\/10.2147\/dddt.S342409 (2022).","journal-title":"Drug Des. Dev. Ther."},{"key":"730_CR253","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s11864-022-00954-4","volume":"23","author":"N Bates","year":"2022","unstructured":"Bates, N., Bello, J. K., Osazuwa-Peters, N., Sullivan, M. D. & Scherrer, J. F. Depression and long-term prescription opioid use and opioid use disorder: implications for pain management in cancer. Curr. Treat. Options Oncol. 23, 348\u2013358 https:\/\/doi.org\/10.1007\/s11864-022-00954-4 (2022).","journal-title":"Curr. Treat. Options Oncol."},{"key":"730_CR254","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3390\/jcm11061594","volume":"11","author":"C Preux","year":"2022","unstructured":"Preux, C. et al. Prevalence of opioid use disorder among patients with cancer-related pain: a systematic review. J. Clin. Med. 11, 1594 https:\/\/doi.org\/10.3390\/jcm11061594 (2022).","journal-title":"J. Clin. Med."},{"key":"730_CR255","doi-asserted-by":"publisher","first-page":"e084500","DOI":"10.1136\/bmjopen-2024-084500","volume":"14","author":"L Ye","year":"2024","unstructured":"Ye, L. et al. Effectiveness of non-pharmacological interventions for pain management in patients with cancer:a protocol for systematic review and network meta-analysis. BMJ Open 14, e084500 https:\/\/doi.org\/10.1136\/bmjopen-2024-084500 (2024).","journal-title":"BMJ Open"},{"key":"730_CR256","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s11764-016-0530-y","volume":"10","author":"GM John","year":"2016","unstructured":"John, G. M. et al. Complementary and alternative medicine use among US cancer survivors. J. Cancer Surviv. 10, 850\u2013864 https:\/\/doi.org\/10.1007\/s11764-016-0530-y (2016).","journal-title":"J. Cancer Surviv."},{"key":"730_CR257","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jama.2018.8907","volume":"320","author":"DL Hershman","year":"2018","unstructured":"Hershman, D. L. et al. Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial. JAMA\u00a0320, 167\u2013176 https:\/\/doi.org\/10.1001\/jama.2018.8907 (2018).","journal-title":"JAMA"},{"key":"730_CR258","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/jamaoncol.2021.0310","volume":"7","author":"JJ Mao","year":"2021","unstructured":"Mao, J. J. et al. Effectiveness of electroacupuncture or auricular acupuncture vs usual care for chronic musculoskeletal pain among cancer survivors: the PEACE randomized clinical trial. JAMA Oncol. 7, 720\u2013727 https:\/\/doi.org\/10.1001\/jamaoncol.2021.0310 (2021).","journal-title":"JAMA Oncol."},{"key":"730_CR259","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ejp.576","volume":"19","author":"EM Khedr","year":"2015","unstructured":"Khedr, E. M. et al. Repetitive transcranial magnetic stimulation in neuropathic pain secondary to malignancy: a randomized clinical trial. Eur. J. Pain 19, 519\u2013527 https:\/\/doi.org\/10.1002\/ejp.576 (2015).","journal-title":"Eur. J. Pain"},{"key":"730_CR260","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.840855","volume":"12","author":"Y Tang","year":"2022","unstructured":"Tang, Y. et al. Analgesic effects of repetitive transcranial magnetic stimulation in patients with advanced non-small-cell lung cancer: a randomized, sham-controlled, pilot study. Front. Oncol. 12, 840855 https:\/\/doi.org\/10.3389\/fonc.2022.840855 (2022).","journal-title":"Front. Oncol."},{"key":"730_CR261","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jocn.2020.01.020","volume":"73","author":"Y Goto","year":"2020","unstructured":"Goto, Y. et al. Pilot study of repetitive transcranial magnetic stimulation in patients with chemotherapy-induced peripheral neuropathy. J. Clin. Neurosci. 73, 101\u2013107 https:\/\/doi.org\/10.1016\/j.jocn.2020.01.020 (2020).","journal-title":"J. Clin. Neurosci."},{"key":"730_CR262","doi-asserted-by":"publisher","DOI":"10.1177\/20503121231209088","volume":"11","author":"Z Yan","year":"2023","unstructured":"Yan, Z. et al. Repetitive transcranial magnetic stimulation for chemotherapy-induced peripheral neuropathy in multiple myeloma: a pilot study. Sage Open Med. 11, 20503121231209088 https:\/\/doi.org\/10.1177\/20503121231209088 (2023).","journal-title":"Sage Open Med."},{"key":"730_CR263","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s12282-024-01598-y","volume":"31","author":"M Kataria","year":"2024","unstructured":"Kataria, M. et al. Assessing the effectiveness of high frequency repetitive transcranial magnetic stimulation for post-mastectomy pain in breast cancer patients: a randomized controlled trial. Breast Cancer 31, 841\u2013850 https:\/\/doi.org\/10.1007\/s12282-024-01598-y (2024).","journal-title":"Breast Cancer"},{"key":"730_CR264","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000101127","volume":"48","author":"Y Katayama","year":"1985","unstructured":"Katayama, Y., Tsubokawa, T., Hirayama, T. & Yamamoto, T. Pain relief following stimulation of the pontomesencephalic parabrachial region in humans: brain sites for nonopiate-mediated pain control. Appl. Neurophysiol. 48, 195\u2013200 https:\/\/doi.org\/10.1159\/000101127 (1985).","journal-title":"Appl. Neurophysiol."},{"key":"730_CR265","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.nec.2014.07.009","volume":"25","author":"OP Keifer Jr.","year":"2014","unstructured":"Keifer, O. P. Jr, Riley, J. P. & Boulis, N. M. Deep brain stimulation for chronic pain: intracranial targets, clinical outcomes, and trial design considerations. Neurosurg. Clin. N. Am. 25, 671\u2013692 https:\/\/doi.org\/10.1016\/j.nec.2014.07.009 (2014).","journal-title":"Neurosurg. Clin. N. Am."},{"key":"730_CR266","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.21037\/apm-23-433","volume":"12","author":"MH Habib","year":"2023","unstructured":"Habib, M. H., Schl\u00f6gl, M., Raza, S., Chwistek, M. & Gulati, A. Interventional pain management in cancer patients\u2014a scoping review. Ann. Palliat. Med. 12, 1198\u20131214 https:\/\/doi.org\/10.21037\/apm-23-433 (2023).","journal-title":"Ann. Palliat. Med."},{"key":"730_CR267","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1136\/bmjspcare-2021-003293","volume":"13","author":"EAS Rouhento","year":"2023","unstructured":"Rouhento, E. A. S., Lehto, J. T. & Kalliom\u00e4ki, M.-L. Peripheral nerve blocks in advanced cancer pain: retrospective case series. BMJ Support. Palliat. Care 13, e287\u2013e290 https:\/\/doi.org\/10.1136\/bmjspcare-2021-003293 (2023).","journal-title":"BMJ Support. Palliat. Care"},{"key":"730_CR268","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/ner.12538","volume":"20","author":"TR Deer","year":"2017","unstructured":"Deer, T. R. et al. The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation 20, 96\u2013132 https:\/\/doi.org\/10.1111\/ner.12538 (2017).","journal-title":"Neuromodulation"},{"key":"730_CR269","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1200\/jco.2002.02.118","volume":"20","author":"TJ Smith","year":"2002","unstructured":"Smith, T. J. et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J. Clin. Oncol. 20, 4040\u20134049 https:\/\/doi.org\/10.1200\/jco.2002.02.118 (2002).","journal-title":"J. Clin. Oncol."},{"key":"730_CR270","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/pm\/pnaa030","volume":"21","author":"TR Deer","year":"2020","unstructured":"Deer, T. R. et al. A systematic literature review of peripheral nerve stimulation therapies for the treatment of pain. Pain Med. 21, 1590\u20131603 https:\/\/doi.org\/10.1093\/pm\/pnaa030 (2020).","journal-title":"Pain Med."},{"key":"730_CR271","first-page":"599","volume":"23","author":"J Karri","year":"2020","unstructured":"Karri, J. et al. Spinal cord stimulation for chronic pain syndromes: a review of considerations in practice management. Pain Physician 23, 599\u2013616 (2020).","journal-title":"Pain Physician"},{"key":"730_CR272","unstructured":"World Health Organization. Left Behind in Pain: Extent and Causes of Global Variations in Access to Morphine for Medical Use and Actions to Improve Safe Access (WHO, 2023)."},{"key":"730_CR273","unstructured":"Quyen, V. T., Hadjiat, Y., Chala, M. B., Nguyen, H. T. & Oluwafemi, A. K. Opioid Analgesics Access in Low-Middle Income Countries (International Association for the Study of Pain, 2025)."},{"key":"730_CR274","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jpainsymman.2024.06.020","volume":"68","author":"EB Andres","year":"2024","unstructured":"Andres, E. B. et al. Opioid access among advanced cancer patients in low- and middle-income countries in Asia. J. Pain Symptom Manag. 68, 352\u2013359 https:\/\/doi.org\/10.1016\/j.jpainsymman.2024.06.020 (2024).","journal-title":"J. Pain Symptom Manag."},{"key":"730_CR275","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03200-4","author":"E Chukwusa","year":"2025","unstructured":"Chukwusa, E. et al. Ethnic disparities in opioid prescribing for cancer pain and associated emergency department visits and hospital admissions in the last three months of life: a retrospective cohort study. Br. J. Cancer https:\/\/doi.org\/10.1038\/s41416-025-03200-4 (2025).","journal-title":"Br. J. Cancer"},{"key":"730_CR276","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.21037\/apm-24-61","volume":"13","author":"RA Rodin","year":"2024","unstructured":"Rodin, R. A. & Smith, C. B. The challenge of opioids in cancer care: balancing equity, safety, and access. Ann. Palliat. Med. 13, 1301\u20131306 https:\/\/doi.org\/10.21037\/apm-24-61 (2024).","journal-title":"Ann. Palliat. Med."},{"key":"730_CR277","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00228-019-02801-2","volume":"76","author":"JW Boland","year":"2020","unstructured":"Boland, J. W. et al. The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European Palliative Care Cancer Symptom Study. Eur. J. Clin. Pharmacol. 76, 393\u2013402 https:\/\/doi.org\/10.1007\/s00228-019-02801-2 (2020).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"730_CR278","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2022-103769","author":"TK Oh","year":"2022","unstructured":"Oh, T. K., Kim, H. G. & Song, I.-A. New, long-term opioid use after lung cancer surgery is associated with reduced 2-year survival: a retrospective population-based cohort study in South Korea. Reg. Anesth. Pain Med. https:\/\/doi.org\/10.1136\/rapm-2022-103769 (2022).","journal-title":"Reg. Anesth. Pain Med."},{"key":"730_CR279","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamaoncol.2022.2191","volume":"8","author":"K Fitzgerald Jones","year":"2022","unstructured":"Fitzgerald Jones, K. et al. Consensus-based guidance on opioid management in individuals with advanced cancer-related pain and opioid misuse or use disorder. JAMA Oncol. 8, 1107\u20131114 https:\/\/doi.org\/10.1001\/jamaoncol.2022.2191 (2022).","journal-title":"JAMA Oncol."},{"key":"730_CR280","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11864-023-01091-2","volume":"24","author":"A Bradley","year":"2023","unstructured":"Bradley, A. & Boland, J. W. Effects of opioids on immune and endocrine function in patients with cancer pain. Curr. Treat. Options Oncol. 24, 867\u2013879 https:\/\/doi.org\/10.1007\/s11864-023-01091-2 (2023).","journal-title":"Curr. Treat. Options Oncol."},{"key":"730_CR281","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1016\/j.bja.2022.12.007","volume":"130","author":"M Sheikh","year":"2023","unstructured":"Sheikh, M., Brennan, P., Mariosa, D. & Robbins, H. A. Opioid medications: an emerging cancer risk factor? Br. J. Anaesth. 130, e401\u2013e403 https:\/\/doi.org\/10.1016\/j.bja.2022.12.007 (2023).","journal-title":"Br. J. Anaesth."},{"key":"730_CR282","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1007\/s00520-020-05329-9","volume":"28","author":"JH Kang","year":"2020","unstructured":"Kang, J. H. et al. Interference with daily functioning by breakthrough pain in patients with cancer. Support. Care Cancer 28, 5177\u20135183 https:\/\/doi.org\/10.1007\/s00520-020-05329-9 (2020).","journal-title":"Support. Care Cancer"},{"key":"730_CR283","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11214-5","volume":"23","author":"G Joshy","year":"2023","unstructured":"Joshy, G. et al. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer. BMC Cancer 23, 774 https:\/\/doi.org\/10.1186\/s12885-023-11214-5 (2023).","journal-title":"BMC Cancer"},{"key":"730_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2020.103707","volume":"111","author":"Y Ma","year":"2020","unstructured":"Ma, Y. et al. Prevalence and risk factors of cancer-related fatigue: a systematic review and meta-analysis. Int. J. Nurs. Stud. 111, 103707 https:\/\/doi.org\/10.1016\/j.ijnurstu.2020.103707 (2020).","journal-title":"Int. J. Nurs. Stud."},{"key":"730_CR285","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2024.108056","volume":"187","author":"C Ee","year":"2024","unstructured":"Ee, C. et al. Lifestyle and integrative oncology interventions for cancer-related fatigue and sleep disturbances. Maturitas 187, 108056 https:\/\/doi.org\/10.1016\/j.maturitas.2024.108056 (2024).","journal-title":"Maturitas"},{"key":"730_CR286","doi-asserted-by":"publisher","first-page":"n1034","DOI":"10.1136\/bmj.n1034","volume":"374","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ 374, n1034 https:\/\/doi.org\/10.1136\/bmj.n1034 (2021).","journal-title":"BMJ"},{"key":"730_CR287","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00432-025-06093-1","volume":"151","author":"G Wang","year":"2025","unstructured":"Wang, G. & Pan, S. The impact of sleep interventions combined with enhanced nutritional support on sleep quality, nutritional status, pain management, psychological well-being, and quality of life in postoperative colon cancer patients. J. Cancer Res. Clin. Oncol. 151, 50 https:\/\/doi.org\/10.1007\/s00432-025-06093-1 (2025).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"730_CR288","doi-asserted-by":"publisher","first-page":"CD006911","DOI":"10.1002\/14651858.CD006911.pub4","volume":"10","author":"J Bradt","year":"2021","unstructured":"Bradt, J., Dileo, C., Myers-Coffman, K. & Biondo, J. Music interventions for improving psychological and physical outcomes in people with cancer. Cochrane Database Syst. Rev. 10, CD006911 https:\/\/doi.org\/10.1002\/14651858.CD006911.pub4 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"730_CR289","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1200\/jco.2011.37.0437","volume":"30","author":"S Sheinfeld Gorin","year":"2012","unstructured":"Sheinfeld Gorin, S. et al. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J. Clin. Oncol. 30, 539\u2013547 https:\/\/doi.org\/10.1200\/jco.2011.37.0437 (2012).","journal-title":"J. Clin. Oncol."},{"key":"730_CR290","doi-asserted-by":"publisher","DOI":"10.1002\/pon.6308","volume":"33","author":"SM DeForge","year":"2024","unstructured":"DeForge, S. M. et al. Pain coping, multidisciplinary care, and mHealth: patients\u2019 views on managing advanced cancer pain. Psychooncology 33, e6308 https:\/\/doi.org\/10.1002\/pon.6308 (2024).","journal-title":"Psychooncology"},{"key":"730_CR291","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1200\/jco.2013.54.4825","volume":"32","author":"KL Syrjala","year":"2014","unstructured":"Syrjala, K. L. et al. Psychological and behavioral approaches to cancer pain management. J. Clin. Oncol. 32, 1703\u20131711 https:\/\/doi.org\/10.1200\/jco.2013.54.4825 (2014).","journal-title":"J. Clin. Oncol."},{"key":"730_CR292","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1177\/13591053251324249","volume":"30","author":"P Kolokotroni","year":"2025","unstructured":"Kolokotroni, P. & Anagnostopoulos, F. The impact of cognitive and existential factors on pain experience and how pain relates to cancer survivors\u2019 fear of recurrence: a systematic review. J. Health Psychol. 30, 3359\u20133377 https:\/\/doi.org\/10.1177\/13591053251324249 (2025).","journal-title":"J. Health Psychol."},{"key":"730_CR293","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101155","volume":"8","author":"L Grassi","year":"2023","unstructured":"Grassi, L. et al. Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline. ESMO Open 8, 101155 https:\/\/doi.org\/10.1016\/j.esmoop.2023.101155 (2023).","journal-title":"ESMO Open"},{"key":"730_CR294","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.31557\/apjcp.2022.23.6.2035","volume":"23","author":"F Jan","year":"2022","unstructured":"Jan, F., Singh, M., Syed, N. A., Wani, D. & Bashir, M. Effectiveness of cognitive restructuring on intensity of pain in cancer patients: a pilot study in oncology department of tertiary care hospital. Asian Pac. J. Cancer Prev. 23, 2035\u20132047 https:\/\/doi.org\/10.31557\/apjcp.2022.23.6.2035 (2022).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"730_CR295","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ejp.2067","volume":"27","author":"J Duarte","year":"2023","unstructured":"Duarte, J., Bj\u00f6rkstrand, F. K., McCracken, L. & Perrin, S. The contribution of psychological flexibility to functioning in people living with cancer-related pain. Eur. J. Pain 27, 413\u2013423 https:\/\/doi.org\/10.1002\/ejp.2067 (2023).","journal-title":"Eur. J. Pain"},{"key":"730_CR296","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21165","volume":"63","author":"GH Montgomery","year":"2013","unstructured":"Montgomery, G. H., Schnur, J. B. & Kravits, K. Hypnosis for cancer care: over 200 years young. CA Cancer J. Clin. 63, 31\u201344 https:\/\/doi.org\/10.3322\/caac.21165 (2013).","journal-title":"CA Cancer J. Clin."},{"key":"730_CR297","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ctcp.2018.12.014","volume":"34","author":"G De Paolis","year":"2019","unstructured":"De Paolis, G. et al. The effectiveness of progressive muscle relaxation and interactive guided imagery as a pain-reducing intervention in advanced cancer patients: a multicentre randomised controlled non-pharmacological trial. Complement. Ther. Clin. Pract. 34, 280\u2013287 https:\/\/doi.org\/10.1016\/j.ctcp.2018.12.014 (2019).","journal-title":"Complement. Ther. Clin. Pract."},{"key":"730_CR298","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-024-01418-2","volume":"23","author":"W Xia","year":"2024","unstructured":"Xia, W. et al. Experiences of patients with advanced cancer coping with chronic pain: a qualitative analysis. BMC Palliat. Care 23, 94 https:\/\/doi.org\/10.1186\/s12904-024-01418-2 (2024).","journal-title":"BMC Palliat. Care"},{"key":"730_CR299","doi-asserted-by":"publisher","first-page":"EVIDoa2400423","DOI":"10.1056\/EVIDoa2400423","volume":"4","author":"AJ Mannes","year":"2025","unstructured":"Mannes, A. J. et al. Treatment of intractable cancer pain with resiniferatoxin \u2013 an interim study. N. Engl. J. Med. Evid. 4, EVIDoa2400423 https:\/\/doi.org\/10.1056\/EVIDoa2400423 (2025).","journal-title":"N. Engl. J. Med. Evid."},{"key":"730_CR300","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81500-4","volume":"11","author":"E Salvo","year":"2021","unstructured":"Salvo, E. et al. TNF\u03b1 promotes oral cancer growth, pain, and Schwann cell activation. Sci. Rep. 11, 1840 https:\/\/doi.org\/10.1038\/s41598-021-81500-4 (2021).","journal-title":"Sci. Rep."},{"key":"730_CR301","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/papr.13273","volume":"23","author":"YL Hsieh","year":"2023","unstructured":"Hsieh, Y.-L., Chen, H.-Y., Lin, C.-R. & Wang, C.-F. Efficacy of epidural analgesia for intractable cancer pain: a systematic review. Pain Pract. 23, 956\u2013969 https:\/\/doi.org\/10.1111\/papr.13273 (2023).","journal-title":"Pain Pract."},{"key":"730_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111300","volume":"214","author":"E Oldenburger","year":"2025","unstructured":"Oldenburger, E. et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases: a second update. Radiother. Oncol. 214, 111300 https:\/\/doi.org\/10.1016\/j.radonc.2025.111300 (2025).","journal-title":"Radiother. Oncol."},{"key":"730_CR303","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neurom.2022.01.023","volume":"25","author":"JE Crowther","year":"2022","unstructured":"Crowther, J. E., Chen, G. H., Legler, A. & Gulati, A. Spinal cord stimulation in the treatment of cancer pain: a retrospective review. Neuromodulation 25, 693\u2013699 https:\/\/doi.org\/10.1016\/j.neurom.2022.01.023 (2022).","journal-title":"Neuromodulation"},{"key":"730_CR304","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neurom.2023.06.009","volume":"27","author":"EW Sudek","year":"2024","unstructured":"Sudek, E. W., Mach, S., Huh, B. & Javed, S. Use of temporary percutaneous peripheral nerve stimulation in an oncologic population: a retrospective review. Neuromodulation 27, 118\u2013125 https:\/\/doi.org\/10.1016\/j.neurom.2023.06.009 (2024). This pilot study demonstrates >50% sustained pain relief after short-term peripheral nerve stimulation, signalling the clinical entry of neuromodulation into cancer pain management.","journal-title":"Neuromodulation"},{"key":"730_CR305","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/ajp.0000000000000310","volume":"32","author":"J Guan","year":"2016","unstructured":"Guan, J., Tanaka, S. & Kawakami, K. Anticonvulsants or antidepressants in combination pharmacotherapy for treatment of neuropathic pain in cancer patients: a systematic review and meta-analysis. Clin. J. Pain 32, 719\u2013725 (https:\/\/doi.org\/10.1097\/ajp.0000000000000310 (2016).","journal-title":"Clin. J. Pain"},{"key":"730_CR306","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-023-01126-3","volume":"22","author":"JH Tsai","year":"2023","unstructured":"Tsai, J.-H. et al. Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment. BMC Palliat. Care 22, 4 https:\/\/doi.org\/10.1186\/s12904-023-01126-3 (2023).","journal-title":"BMC Palliat. Care"},{"key":"730_CR307","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EM Smith","year":"2013","unstructured":"Lavoie Smith, E. M. et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309, 1359\u20131367 https:\/\/doi.org\/10.1001\/jama.2013.2813 (2013). This randomized phase III trial demonstrates duloxetine superiority over placebo for painful chemotherapy-induced peripheral neuropathy, providing the first high-level evidence for a targeted adjuvant analgesic in cancer pain.","journal-title":"JAMA"},{"key":"730_CR308","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","volume":"19","author":"G Sgouros","year":"2020","unstructured":"Sgouros, G., Bodei, L., McDevitt, M. R. & Nedrow, J. R. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat. Rev. Drug Discov. 19, 589\u2013608 https:\/\/doi.org\/10.1038\/s41573-020-0073-9 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"730_CR309","first-page":"55","volume":"92","author":"G Kettyle","year":"2023","unstructured":"Kettyle, G. Multidisciplinary approach to cancer pain management. Ulster Med. J. 92, 55\u201358 (2023).","journal-title":"Ulster Med. J."},{"key":"730_CR310","doi-asserted-by":"publisher","first-page":"e2342482","DOI":"10.1001\/jamanetworkopen.2023.42482","volume":"6","author":"AS Epstein","year":"2023","unstructured":"Epstein, A. S. et al. Acupuncture vs massage for pain in patients living with advanced cancer: the IMPACT randomized clinical trial. JAMA Netw. Open 6, e2342482 https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.42482 (2023).","journal-title":"JAMA Netw. Open"},{"key":"730_CR311","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/pon.5821","volume":"31","author":"N Danon","year":"2022","unstructured":"Danon, N., Al-Gobari, M., Burnand, B. & Rodondi, P.-Y. Are mind\u2013body therapies effective for relieving cancer-related pain in adults? A systematic review and meta-analysis. Psychooncology 31, 345\u2013371 https:\/\/doi.org\/10.1002\/pon.5821 (2022).","journal-title":"Psychooncology"},{"key":"730_CR312","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s11864-022-01010-x","volume":"23","author":"AK Wong","year":"2022","unstructured":"Wong, A. K., Somogyi, A. A., Rubio, J. & Philip, J. The role of pharmacogenomics in opioid prescribing. Curr. Treat. Options Oncol. 23, 1353\u20131369 https:\/\/doi.org\/10.1007\/s11864-022-01010-x (2022).","journal-title":"Curr. Treat. Options Oncol."},{"key":"730_CR313","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41397-019-0131-z","volume":"20","author":"KWD Ho","year":"2020","unstructured":"Ho, K. W. D., Wallace, M. R., Staud, R. & Fillingim, R. B. OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study. Pharmacogenomics J. 20, 471\u2013481 https:\/\/doi.org\/10.1038\/s41397-019-0131-z (2020).","journal-title":"Pharmacogenomics J."},{"key":"730_CR314","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54009-9","volume":"14","author":"LM Haupt","year":"2024","unstructured":"Haupt, L. M. et al. The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life. Sci. Rep. 14, 3411 (2024). This study shows that allelic variants strongly influence opioid efficacy and toxicity in cancer pain, supporting ongoing efforts towards genotype-informed opioid prescribing.","journal-title":"Sci. Rep."},{"key":"730_CR315","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pain.2005.03.032","volume":"116","author":"TT Rakv\u00e5g","year":"2005","unstructured":"Rakv\u00e5g, T. T. et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 116, 73\u201378, https:\/\/doi.org\/10.1016\/j.pain.2005.03.032 (2005).","journal-title":"Pain"},{"key":"730_CR316","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/phar.2875","volume":"43","author":"SA Mosley","year":"2023","unstructured":"Mosley, S. A. et al. CYP2D6-guided opioid therapy for adults with cancer pain: a randomized implementation clinical trial. Pharmacotherapy 43, 1286\u20131296 https:\/\/doi.org\/10.1002\/phar.2875 (2023).","journal-title":"Pharmacotherapy"},{"key":"730_CR317","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/sj.tpj.6500406","volume":"7","author":"J Kirchheiner","year":"2007","unstructured":"Kirchheiner, J. et al. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J. 7, 257\u2013265 https:\/\/doi.org\/10.1038\/sj.tpj.6500406 (2007).","journal-title":"Pharmacogenomics J."},{"key":"730_CR318","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/clpt.2008.157","volume":"85","author":"P Madadi","year":"2009","unstructured":"Madadi, P. et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin. Pharmacol. Ther. 85, 31\u201335 https:\/\/doi.org\/10.1038\/clpt.2008.157 (2009).","journal-title":"Clin. Pharmacol. Ther."},{"key":"730_CR319","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/s0140-6736(06)69255-6","volume":"368","author":"G Koren","year":"2006","unstructured":"Koren, G., Cairns, J., Chitayat, D., Gaedigk, A. & Leeder, S. J. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 368, 704 https:\/\/doi.org\/10.1016\/s0140-6736(06)69255-6 (2006).","journal-title":"Lancet"},{"key":"730_CR320","first-page":"1146","volume":"29","author":"V Subrahmanyam","year":"2001","unstructured":"Subrahmanyam, V. et al. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metab. Dispos. 29, 1146\u20131155 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"730_CR321","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/s0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame, S. et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 387, 1644\u20131656 https:\/\/doi.org\/10.1016\/s0140-6736(16)00161-6 (2016).","journal-title":"Lancet"},{"key":"730_CR322","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6358624","volume":"2018","author":"A Samulowitz","year":"2018","unstructured":"Samulowitz, A., Gremyr, I., Eriksson, E. & Hensing, G. \u201cBrave men\u201d and \u201cemotional women\u201d: a theory-guided literature review on gender bias in health care and gendered norms towards patients with chronic pain. Pain Res. Manag. 2018, 6358624 https:\/\/doi.org\/10.1155\/2018\/6358624 (2018).","journal-title":"Pain Res. Manag."},{"key":"730_CR323","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jpain.2009.10.002","volume":"10","author":"KO Anderson","year":"2009","unstructured":"Anderson, K. O., Green, C. R. & Payne, R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J. Pain 10, 1187\u20131204 https:\/\/doi.org\/10.1016\/j.jpain.2009.10.002 (2009).","journal-title":"J. Pain"},{"issue":"Suppl 11","key":"730_CR324","doi-asserted-by":"publisher","first-page":"xi14","DOI":"10.1093\/annonc\/mdt499","volume":"24","author":"J Cleary","year":"2013","unstructured":"Cleary, J. et al. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI). Ann. Oncol. 24(Suppl. 11), xi14\u2013xi23 https:\/\/doi.org\/10.1093\/annonc\/mdt499 (2013).","journal-title":"Ann. Oncol."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00730-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00730-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00730-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:02:42Z","timestamp":1787209362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-026-00730-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":324,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1038\/s41572-026-00730-w","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"20 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"55"}}